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Abstract 
Background: Reduced muscle mass seen with age, often referred to as age-related 
atrophy or sarcopenia, has negative effects on physical function. There are frequent 
reports of a blunted anabolic response in elderly to both resistance exercise (RE) and 
protein intake, and this is referred to as anabolic resistance. Translation initiation and 
elongation signaling responses after a single exposure of RE and protein intake is 
often used as indexes of anabolic responsiveness.  
Aim: To examine whether habitual intake of un-denatured and specially filtrated 
native whey (NW) with a faster absorption-rate and higher leucine content than milk, 
would lead to greater hypertrophy and 1RM strength-gains after 11 weeks of 
resistance training, mirrored by increased anabolic signaling.  
Methods: Two groups of  elderly (total of 9 men and 7 women), mean age 73 years 
completed a 10RM whole-body workout combined with intake of 20 g NW- or milk-
protein before (acute 1) and after (acute 2) 11 weeks of strength training. Muscle 
biopsies were collected from m. vastus lateralis pre- and 2 hour post-exercise. Tissue 
samples were analyzed for total protein- and phosphorylated levels of p706SK, 4E-
BP1 and eEF2.  
Results: The ratio of phosphorylated/total p706SK increased significantly on acute 2, 
and with a strong tendency on acute 1. Ratio of phosphorylated/total 4E-BP1 and 
eEF2 remained unchanged from baseline in both groups on acute 1 and 2. There was 
no differences (P>0.05) in any of the studied signaling proteins within each group, or 
between groups on either acute day. Both groups experienced similar increases in m. 
vastus lateralis thickness (+6-7%), lean body mass (2.1-2.3 kg) and 1RM strength 
(+20-40%). Phosphorylation patterns of our studied signaling proteins 2 hours post- 
RE and -protein intake were not correlated to any long-term outcome measure on an 
individual level.  
Discussion and conclusion: The difference in leucine-content between NW and milk 
might have been too small to detect differences between our groups. Supplementation 
with equal amounts of protein from NW and milk resulted in similar signaling for 
muscle hypertrophy and similar gains in m. vastus lateralis muscle thickness, muscle 
mass and muscle strength. Our findings emphasize that acute measures of intracellular 
anabolic signaling responses downstream of mTORC1 should be interpreted with 
caution if used as indexes of responsiveness to repeated RE and protein intake.   
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Background 
Maintaining an adequate amount of skeletal muscle is crucial for human locomotion, 
sports performance and several health parameters such as avoiding obesity, type 2 
diabetes and age-related atrophy in the elderly. In this context it is of the greatest 
importance to develop efficient strategies to enhance or maintain muscle mass. 
Interventions combining resistance exercise (RE) and  protein-intake show that these 
external stimuli are potent regulators of muscle mass and strength gains (Cermak et 
al, 2012). Understanding how these external stimuli affects internal signaling 
cascades related to hypertrophy/atrophy will increase the efficacy of 
recommendations with regards to resistance training and protein intake. 
 
There are frequent reports of a blunted response in elderly to both exercise and 
protein intake (Cuthbertson et al, 2005; Katsanos et al, 2005; Kumar et al, 2009; 
Paddon-Jones et al, 2004), and this is referred to as anabolic resistance (Cuthbertson 
et al, 2005). Data is unequivocal in regards to diminishing muscle mass seen with age, 
often referred to as age-related atrophy or sarcopenia (Janssen & Ross, 2005). This 
loss of muscle mass could be a consequence of anabolic resistance or a more 
sedentary lifestyle as seen with aging. Anabolic resistance could lead to a more 
sedentary lifestyle, as well as a sedentary lifestyle itself could lead to anabolic 
resistance. Nonetheless, it becomes apparent that in the aging population, we need 
efficient countermeasures to overcome the well-documented anabolic resistance and 
reductioins in muscle mass seen with age. 
 
Of different exercise-modes, RE is by far the most efficient countermeasure to 
atrophy. There is wealth of evidence that progressive resistance training causes 
hypertrophy in healthy individuals, regardless of gender and age (Peterson et al, 2010; 
Peterson et al, 2011; Cermak et al, 2012). Protein intake has been examined with 
regards to dosing, timing and types of protein used.  These factors are often 
mentioned to be main contributors to the varying degrees of subsequent anabolic 
signaling and hypertrophy in relation to protein intake. While it is well established 
that the most potent anabolic effects of protein intake require sufficient dosing and an 
amino acid profile containing a high amount of essential amino acids (especially 
leucine), there is limited data showing protein timing to be of significant importance, 
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as long as sufficient amount of protein is consumed. Of the most frequent protein 
sources examined, whey, soy and casein are all proven to enhance muscle protein 
synthesis (MPS), but of different magnitude. Whey has been shown to be superior to 
soy and casein in creating a fast and robust MPS-response, often explained by its 
faster digestion-rate and higher leucine-content (Tang et al, 2009; Reidy et al, 2014).  
 
In general, measuring functionally relevant changes in muscle mass over time is done 
with different methods of a non-invasive character (Ultrasound, DXA-scan and MRI). 
Acute changes are measured by more invasive methods (tracer infusion and biopsies).  
Methods of a non-invasive character are generally used to quantitatively assess 
changes in muscle mass and size, fat mass, bone mass etc. Combining such outcome-
measures with more invasive methods can also give insight into the mechanisms 
behind these changes. With tracer infusion of labelled amino acids one can calculate 
and analyze the temporal MPS accumulation in the acute post-workout phase. Muscle 
tissue from biopsies is frequently used together with immunohistochemical and 
Western blot analysis to reveal changes in the phosphorylation patterns of 
intramuscular signaling proteins related to MPS (Cuthbertson et al, 2005; Reitelseder 
et al, 2011; Churchward-Venne et al, 2012).  
 
Theoretically, acute anabolic responses to exercise and protein intake would 
accumulate and translate into hypertrophy after a prolonged intervention period. 
Acute studies are often with participants in the fasted state, and in highly controlled 
laboratory settings, not necessarily reflecting everyday life. Combining both non-
invasive and invasive methods within the same study group over a substantial 
timeframe could give further insight to how we can relate acute intramuscular 
changes with long-term achieved hypertrophy and strength gains. Before exercise and 
nutritional strategies to slow or reverse the progression of sarcopenia can be 
maximized, there are several areas of research that still require further investigation.  
 
Translation initiation and elongation signaling responses after a single exposure of RE 
and protein intake is often used as indexes of anabolic responsiveness. By collecting 
biopsies and through subsequent Western-blot analysis we wanted to examine 
whether hypertrophy and strength-gains are mirrored by anabolic intracellular 
signaling responses. To make data from this study applicable to a larger population 
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we have included both men and women. This study could provide an improved 
understanding of the cellular mechanisms that contribute to the protein synthetic 
response in skeletal muscle, thus provide a basis to develop more promising exercise 
and protein-intake strategies.  
 
We have conducted a randomized controlled longitudinal study in an elderly 
population combining measures of long-term hypertrophy, strength gains and body 
composition changes with acute intracellular responses. By this study-design we 
wanted to examine whether habitual intake native whey with a faster absorption-rate 
and higher leucine content than milk (Laahne J.A, 2013; Aas, S, 2014), would lead to 
greater hypertrophy and 1RM strength gains after 11 weeks of resistance training. 
Furthermore, we wanted to examine whether greater hypertrophy and strength gains 
with native whey were mirrored by increased anabolic intramuscular signaling, 
thought to give an anabolic advantage. 
 
1.1. Hypothesis 
Supplementation with native whey immediately after resistance exercise will lead to 
greater activation of key signaling proteins downstream of mTORC1 than consuming 
the same amount of protein through milk, resulting in greater hypertrophy and 1RM 
strength gains in elderly men and women after 11 weeks of strength training. 
Furthermore, we expect 11 weeks of strength training and protein supplementation to 
be efficient countermeasures to the anabolic resistance in elderly, and expect 
enhanced anabolic signaling post-intervention compared to pre-intervention.  
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2. Theory 
2.1. The dynamic equilibrium of human skeletal muscle and 
net protein balance 
Human skeletal muscle exist in a dynamic equilibrium which constantly responds to 
the load of training and energy intake to determine the rate of muscle protein 
synthesis (MPS) and breakdown (MPB) (Adams & Bamman, 2012). The dynamic 
state of MPS and MPB (MPS-MPB = net protein balance) will over time determine 
subsequent hypertrophy/atrophy/equilibrium. In healthy individuals, net protein 
balance is determined and constantly altered, mainly by external stimuli such as 
mechanical stimuli (e.g. RE) and nutrients (protein intake) (Tang et al, 2009; Tipton 
et al, 1999).  
 
MPB exceeds MPS in the post absorptive (fasted) state and MPS exceeds MPB in the 
postprandial (fed) state.  Post-exercise, both MPS and MPB remain elevated, and 
MPS exceeds MPB only when amino acids are available (Biolo et al, 1995; Tipton et 
al, 1999). To understand how net protein balance determines subsequent 
hypertrophy/atrophy we have to map out how external stimuli (e.g. RE and protein 
intake) translates into intracellular signaling cascades and subsequent positive net 
protein balance. At the most fundamental level it is necessary to up-regulate the 
translational machinery to sustain a net increase in protein balance and achieve 
hypertrophy. MPS is individually up regulated by both RE (Phillips et al, 1997; Burd 
et al, 2010) and protein intake (Biolo et al, 1997; Moore et al 2009). The combination 
of the two stimuli has an additive effect on MPS, causing a more potent positive 
effect on net protein balance than either stimulus by itself (Dreyer et al, 2008; Moore 
et al, 2009; Burd et al, 2010). RE and protein intake in relation to MPS will be further 
elucidated in sections below. 
 
MPB is less documented and understood than MPS in vivo, because of more difficult 
and less developed study-techniques of MPB after exercise and/or protein intake 
(Glynn et al, 2010). There are multiple processes involved in MPB including the 
ubiquitin-proteasome system (UPS), lysosomal and calcium-activated systems, and 
caspases (Fry et al, 2013). Within the UPS, there are two E3 ubiquitin ligases called 
MuRF1 (muscle specific RING Finger 1) and MAFbx (muscle atrophy F-box, also 
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known as atrogin-1). Both these ligases are regulated through the Forkhead box 
(FOX) family of transcription factors (FOXO1, FOXO3a, FOXO4), inhibited by Akt 
through phosphorylation (Glynn et al, 2010; Fry et al, 2013). High levels of insulin 
activate Akt, so even though carbohydrate ingestion itself has no effect on MPS 
(Koopman et al, 2007), it has been shown to reduce MPB through Akt, when provided 
in sufficient amounts (>40 g) after exercise (Borsheim et al, 2004). Thus, the role of 
insulin in net protein balance is limited to minor anti-catabolic effect (reduced MPB) 
(Glynn et al, 2010, Fry et al, 2013). Furthermore, there appears to be no difference in 
MPB post-exercise between young and elderly (Fry et al, 2013), making MPS the 
main target for strategies to induce hypertrophy/maintaining muscle mass. At the 
same time a certain level of MPB is necessary to remove proteins that are no longer 
functional, thus completely removing MPB remains disadvantageous. 
 
2.2. Resistance Exercise and MPS 
Independent of contraction-type, RE has been shown to increase MPS for up to 48 
hours post-exercise in both genders in an untrained group (Phillips, et al, 1997), 
whereas in a trained group it was elevated for 24 hours (Tang et al, 2008). Exercise-
induced MPS is prolonged and of greater magnitude in the contractile elements than 
the sarcoplasmic protein synthesis (Moore et al, 2009). The same study (Moore et al, 
2009) showed that the sarcoplasmic protein synthesis was exclusively stimulated by 
protein intake. Intensity and volume has been shown to determine the MPS-response 
to an RE bout, with increased volume and intensity augmenting and prolonging the 
MPS-response post-exercise (Kumar et al, 2009; Burd et al, 2010). Both young and 
old showed no significant increase in MPS at intensities <40% of 1RM whereas at 
intensities >60% of 1RM, MPS can increase 2- to 3-fold (Kumar et al, 2009). 
However, this does not infer that RE at lower intensities is incapable of inducing an 
MPS-response, if volume is increased (Burd et al, 2010). At 30% of 1RM, the 
magnitude of MPS-response is comparable to 90% of 1RM, if performed to failure 
and volume of work is not matched (Burd et al, 2010). Furthermore, RE stimulates 
MPS by increasing amino acid transport into active skeletal muscles (Biolo et al, 
1995) an effect shown to be independent of age and gender (Drummond et al, 2011). 
RE up regulates both MPS and MPB, thus making post-exercise protein-intake 
necessary to support a lasting MPS-response. If one remains in the post absorptive 
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state, MPS is depressed and MPB stays elevated, causing a negative net protein 
balance (Biolo et al, 1995; Phillips et al, 1999; Tipton et al, 1999). 
 
2.3. Protein intake and MPS 
Increased availability of circulating amino acids leads to a more positive net protein 
balance at rest (Biolo et al, 1997; Smith et al, 1998) and after resistance-exercise 
(Biolo et al, 1997; Phillips et al, 1997). The anabolic effects of feeding are shown to 
be entirely contributed by the essential amino acid (EEA) content (Cuthbertson et al, 
2005; Volpi et al, 2003). Adding additional carbohydrate post-exercise does not 
enhance the MPS-response (Koopman et al, 2007). Cuthbertson et al (2005) showed 
that EEA stimulates MPS independently of insulin, and that a basal rate of MPS is not 
decreased in the elderly compared to the young. Furthermore, a decreased sensitivity 
and delayed responsiveness to EEA intake in the elderly has been shown (Drummond 
et al, 2008; Paddon-Jones et al, 2004).  
 
The anabolic effect of EEA in the young is dose-dependent from 2.5 g and saturates at 
amounts equivalent of  ~10 g EEA,  ~2.1 g leucine (Cuthbertson et al, 2005) or ~20 g 
of high quality protein (Moore et al, 2009).  The MPS response peaks ~2 hours after 
protein intake, and at this time point skeletal muscle becomes refractory to further 
stimulation, despite continuous infusion of amino acids (Bohé et al, 2001; Atherton et 
al, 2010). This EEA saturation is termed the “muscle full” concept (Atherton et al, 
2010). The importance of dosing rather than delivery-profile of protein intake has 
been reported by two recent studies (Kim et al, 2015; Mitchell et al, 2015). Kim et al 
(2015) showed an increase in MPS when doubling the recommended dietary 
allowance (RDA) in elderly, but no effect of how this protein amount was spread out 
during the day. Furthermore, Mitchell et al (2015) showed that equal protein doses 
gave the same MPS response and muscle-full effect regardless of whether protein 
intake was ingested as a bolus or spread out in smaller portions. In summary, the 
anabolic effects of feeding are entirely contributed by EEA-content, which according 
to the muscle full concept has a saturating response at around 20 g high quality 
protein, ~10 g EEA and ~2 g leucine 
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2.4. Additive effect of resistance exercise and protein intake 
The combination of RE and protein intake has an additive effect on net protein 
balance that exceeds either of the stimuli alone (Biolo et al, 1995; Biolo et al, 1997; 
Dreyer et al, 2008; Moore et al, 2009; Burd et al, 2010). The time aspect of these 
anabolic stimuli is varied, a result of whether they are combined or not, and on the 
age and training status of the population examined (Phillips et al, 1997; Tang et al, 
2008).  
 
Protein intake results in an increased MPS-response which diminishes after ~2 hours 
(Bohe et al, 2001; Atherton et al, 2010). With prior RE and subsequent protein intake, 
MPS can be elevated for up to 48 hours in an untrained population (Phillips et al, 
1997). Provision of sufficient EEA is critical to the induction of a positive net protein 
balance by exercise, with an EEA-deficiency abolishing this effect (Biolo et al, 1997). 
After unilateral knee-extension was performed for 8 weeks with the untrained leg 
acting as a control, MPS returned to baseline 28 hours after an acute bout of RE in the 
trained leg whereas MPS was significantly elevated in the untrained leg after 28 hours 
(Tang et al, 2008). In the same study (Tang et al, 2008) MPS in the trained leg was 
significantly elevated above the untrained leg at 4 hours post-exercise, showing a 
faster rise and decline in MPS. Because of a sustained MPS >28 hours, the untrained 
leg showed a greater total MPS-response to acute RE than the trained leg (Tang et al, 
2008). 
 
RE improves the hypertrophic response to protein intake by widening the previously 
described ”muscle full” concept. This widening allows for more amino acids to be 
incorporated into muscle protein during the postprandial period in both young and old 
(Pennings et al, 2011) but the effects are dependent on protein source (Yang et al, 
2012a; Yang et al, 2012b). Elderly men aged 70, showed an incremental MPS-
response to whey intakes ranging from 20 g to 40 g after RE, but a saturated MPS-
response at just 20 g of whey, at rest (Yang et al, 2012b). When soy was used as a 
protein source, a more modest effect on MPS was shown with similar dosing (Yang et 
al, 2012a). In terms of the anabolic effect of EEA’s, the branched-chain amino acid 
(BCAA) leucine has received special attention. More on different protein sources will 
be further elucidated in the protein source section. 
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2.5. Anabolic resistance 
The dynamic interplay between MPS and MPB governs changes in skeletal muscle 
size. Current methodologies suggest that relative to MPB, the rate of MPS is more 
dynamic and responsive to potent anabolic stimulus, such as the aforementioned RE 
and protein intake (Fry et al, 2013; Dreyer et al, 2008; Moore et al, 2009; Burd et al, 
2010). Theoretically when repeated regularly, acute anabolic responses to these 
stimuli will accumulate over time and lead to gains in muscle size and strength. With 
increasing age, there is a decline in muscle mass with concomitant loss of muscle 
strength, referred to as sarcopenia (Janssen & Ross, 2005). This age-related loss of 
muscle mass is suggested to be a result of blunted responses to anabolic stimuli. 
Compared to young, elderly has been shown to have a blunted and delayed response 
to smaller boluses of protein intake (~10 g EEA) and RE (Moore et al, 2015; 
Cuthbertson et al, 2005; Katsanos et al, 2005; Kumar et al, 2009; Paddon-Jones et al, 
2004) . These blunted responses to protein intake and RE has been termed ”anabolic 
resistance” (Cuthbertson et al, 2005). 
 
Before protein intake is able to stimulate MPS, digestion, absorption, basal rates of 
MPS and amino acid transport into muscle fibers are possible limiting factors for the 
subsequent anabolic response. Early work by Boirie et al (1997) suggested that 
reductions in amino acid absorption and digestion in elderly could explain the blunted 
response to protein intake. Increased first-pass hepatic extraction is shown in elderly 
compared to young, which translates into a larger proportion of amino acids directed 
towards use in internal organs (Boirie et al, 1997; Volpi et al, 1999). In contrast, a 
more recent study (Koopman et al, 2009) showed no difference in first-pass hepatic 
extraction in elderly compared to young. The discrepancy between these studies could 
be related to small repeated feedings (Volpi et al, 1999) in contrast to a single large 
protein intake (Koopman et al, 2009). In spite of these differences, both studies (Volpi 
et al, 1999; Koopman et al, 2009) found no differences in MPS-response to protein 
intake between young an old. Furthermore, basal rates of MPS and MPB do not seem 
to differ between young and old (Cuthbertson et al, 2005; Fry et al, 2013; Katsanos et 
al, 2006), and is independent of gender (Fujita et al, 2007a). 
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2.6. Muscle uptake of dietary amino acids 
As RE and increased amino acid availability increases amino acid transport (Biolo et 
al, 1995; Drummond et al, 2010), the reported blunted MPS responses in elderly 
(Cuthbertson et al, 2005; Drummond et al, 2008; Kumar et al, 2009; Fry et al, 2011) 
could infer reduced amino acid transport into muscle fibers in elderly. In this context 
there are studies that report a more rapid decline in plasma-leucine concentrations in 
younger compared to elderly after protein intake, which may be linked to reduced 
amino acid transport (Drummond et al, 2008; Koopman et al, 2009). 
 
Amino acid transporters (AAT) affect net protein balance in their ability to activate 
the mTORC1-signaling pathway (Drummond et al, 2010; Drummond et al, 2011; 
Dickinson et al, 2014). Especially system-L (LAT1) and system-A (SNAT2) ATT’s 
have received special attention because of their ability to sense changes in EEA 
availability (Dickinson et al, 2014; Drummond et al, 2011). Reduced amino acid 
transport into skeletal muscle could translate into reduced intracellular anabolic 
signaling. A diminished response to RE and protein intake has been reported as 
dampened mTOR signaling in elderly compared to young (Cuthbertson et al, 2005; 
Drummond et al, 2008; Kumar et al, 2009).  
 
In contrast, others have shown no age-related reduction in intracellular signaling after 
RE and protein intake (Farnfield et al, 2012; Reidy et al, 2014). Drummond et al 
(2011) reported that increased EEA availability up-regulated mTORC1-signaling, 
MPS and AAT expression in both young and old, of both genders. Thus, alterations in 
AAT expression and function may be essential for regulating MPS after anabolic 
stimuli such as RE and protein intake. After RE and protein intake there is shown an 
up-regulation of  LAT1 and SNAT2 in both young and elderly (Drummond et al, 
2010; Drummond et al, 2011; Reidy et al, 2014; Dickinson et al, 2014). Furthermore, 
this up regulation of system L and A transporters is shown to coincide with increased 
MPS and phosphorylation of p706SK and 4E-BP1 (Reidy et al, 2014; Dickinson et al, 
2014). Furthermore, Drummond et al (2011) reported increased AAT expression after 
RE to be equal in both young and elderly. In light of these studies (Drummond et al, 
2011; Farnfield et al, 2012; Dickinson et al, 2014) it seems that elderly remain an 
efficient amino acid transport into skeletal muscle, and that participant’s state of being 
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untrained/trained is as an important factor for downstream mTORC1-signalling as 
age. 
 
2.7. Reduced anabolic response to protein intake and 
resistance exercise 
If basal MPS in the post absorptive state is unrelated to age, the anabolic resistance in 
elderly compared to the young must be of postprandial character and/or related to the 
RE-response. It is a common observation that elderly is less sensitive than their 
younger counterparts to protein intake (Cuthbertson et al, 2005; Katsanos et al, 
2005&2006; Moore et al, 2015) and RE (Kumar et al, 2009; Fry et al, 2011). In 
support of this, a meta-analysis consisting of 49 studies and 1328 participants 
(Peterson et al, 2011) identified a negative association between age and gains in lean 
body mass (LBM) after resistance training.  
 
After resistance training without subsequent protein intake, it has been shown a 
greater MPS-response in young compared to the elderly (Kumar et al, 2009; Fry et al, 
2011). Furthermore, protein intake under resting conditions show a need for a larger 
protein intake in the elderly of  >20g protein, >15g EEA to maximally stimulate MPS 
(Cuthbertson et al, 2005; Paddon-Jones et al, 2004; Drummond et al, 2008; Yang et 
al, 2012b). A recent study (Moore et al, 2015) examined graded protein intakes (0-40 
g) at rest, in elderly and young, showing an increased protein intake to be necessary to 
induce a maximal MPS-response in the elderly (0.6 g per kg lean body mass). 
Another recent study (Kim et al, 2015) divided elderly into two groups, one 
consuming the RDA of 0.8 g protein per day (1RDA) and the other consuming double 
the amount (2RDA). After 4 days of diet habituation, the 2RDA-group had close to a 
doubled net protein balance in the fed state, compared to the 1RDA-group.  
 
When RE precedes protein intake there seems to be a higher saturation threshold in 
elderly compared to young, with elderly showing maximal MPS-response at 40 g of 
whey and the young having a saturated response at 20 g of whey (Yang et al, 
2012a&b). Furthermore, Kim et al (2015) showed no effect of how protein quantities 
were spread out during the day, emphasizing the superior importance of protein 
quantity over intake pattern. This has been confirmed in young people were the 
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muscle full effect was dose dependent and not dependent on feeding pattern (bolus vs 
spread) (Mitchell et al (2015). The blunted response in elderly to smaller boluses (7 g) 
of EEA (Katsanos et al, 2005) is restored when EEA is doubled (15 g) (Paddon-Jones 
et al, 2004; Drummond et al, 2008). Drummond et al (2008) showed an equal MPS-
response after RE and 20 g of EEA between young and old over a 6 hour period, with 
the young having a more pronounced MPS-response the first 3 hours, and the elderly 
showing a delayed but increased response between 3-6 hours. Combining resistance 
training and ingestion of 20 g casein (~7 g EEA) was shown to induce equal MPS-
responses in young and old (Pennings et al, 2011). At rest, a moderate-protein meal of 
lean beef (30 g protein) was shown to induce a similar MPS-response in young and 
old (Symons et al 2009). Based on the above studies, elderly seem to respond to EEA, 
albeit in a delayed fashion, and may require larger doses than their younger 
counterparts. 
 
The findings in the above mentioned studies (Katsanos et al, 2005; Paddon-Jones et 
al, 2004; Symons et al, 2009; Moore et al, 2015; Kim et al, 2015; Yang et al, 
2012a&b; Mitchell et al, 2015) is further elucidated in several recent reviews 
(Deer&Volpi, 2015; Wall et al, 2014; Deutz et al, 2014), and it seems beneficial for 
the elderly to consume ~30 g of protein per meal and about 1.2-1.6 g/kg of protein per 
day.  
 
2.8. Protein source 
In addition to the demand for increased protein quantities in elderly, different sources 
of protein has been shown to affect the MPS-response of various magnitudes. Whey 
has been proven superior to casein and the plant-based soy-protein (Tang et al, 2009; 
Yang et al, 2012a&b; Burd et al, 2012). Following RE and matched intakes of 10 g 
EEA through either whey, soy or casein, digestion rates and MPS-response of the 
different protein sources proved to be whey>soy>casein in young men (Tang et al, 
2009). Despite the fact that both whey and soy were deemed ”fast”-proteins in this 
study (Tang et al, 2009), whey had a superior MPS-response, possibly due to higher 
leucine content than in soy.  
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Whey protein is usually derived from cheese production, but newer technology allows 
extraction of whey from milk through filtration techniques, resulting in a higher 
leucine content. Native whey used in this study is produced in this manner, leaving 
the whey un-denatured as opposed to traditional whey supplements. Ingestion of 
native whey has been shown to be more readily absorbed, with significantly raised 
blood leucine concentration compared to milk and other whey supplements (Laahne, 
J.A, 2013; Aas, S, 2014).  
 
2.9. Leucine 
In addition to the effect of absorption-rate (Tang et al, 2009), leucine content is shown 
to be an important factor for subsequent MPS-response (Burd et al, 2012; Yang et al, 
2012a&b) and is not dependent on any of the other amino acids (Katsanos et al, 2005; 
Rieu et al, 2006; Casperson et al, 2012). Other amino acids seem in this context to be 
only permissive for a longer lasting MPS-response (Tipton et al, 1999). Whey protein 
(2.8 g leucine) induced a greater MPS-response than casein (1.6 g leucine) when 
given as 20 g doses, both at rest and post-exercise in elderly (Burd et al, 2012). 
Corroborating these data, Yang et al (2012a&b) supplemented with 20 g and 40 g of 
either whey or soy protein, given at rest and post-exercise in elderly. Combining data 
from these studies (Yang et al, 2012a&b), whey induced a superior MPS-response 
compared to soy at both 20 g and 40 g dosing, both at rest and post-exercise. Whey 
and soy had a leucine-content of 2 g and 1.6 g respectively at 20 g supplementation. 
Tang et al (2009) also contributes some of the increased MPS-response in their study 
to increased leucine content in whey (2.3 g) compared to soy and casein (both being 
1.8 g).  
 
The attenuated MPS-response to protein intake in elderly is diminished by increasing 
leucine content (Katsanos et al, 2006; Rieu, 2006; Casperson et al, 2012; Dickinson et 
al, 2014). When given 6.7 g of EEA post-exercise, Katsanos et al (2006) showed that 
increasing leucine content from 26% to 41% restored the MPS-response in the 
elderly, reaching similar MPS as seen in the young. Furthermore, Churchward-Venne 
et al (2012) supplemented a sub-optimal dose of 6.25 g whey with 3 g leucine and 
saw a similar MPS-response as with 25 g of whey, both at rest and after RE. Rieu et al 
(2006) reported improved MPS when supplementing with 4 g of leucine after 
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ensuring a habitual intake of 0.8 g protein/day for 4 consecutive days before testing. 
Elderly men (mean age 69 years) went through an 8 hour isocaloric infusion protocol 
and the effect of leucine supplementation on MPS were entirely attributed to leucine 
content, as the only difference between groups was plasma leucine concentrations 
(Rieu et al, 2006).  
 
Casperson et al (2012) reported increased MPS in elderly in both the post absorptive 
and postprandial state after 2 weeks of leucine supplementation. Leucine was not 
given on day 1 and 15 (testing days) but given to one participant-group as 4 g doses 
on top of their normal meals 3 times per day. These findings were also mirrored by 
similar increases in p706SK- and 4E-BP1-phosphorylation (Casperson et al, 2012) 
Another study (Wall et al, 2013) corroborated the above observations, and extended 
these findings by showing that a larger proportion of total ingested protein were 
directed towards MPS with leucine supplementation. However, when examining the 
prolonged effects of leucine supplementation, no extra effect has been shown 
(Verhoeven et al, 2009). Verhoeven et al (2009) supplemented each main meal with 
2.5 g of leucine, three times per day for 3 months with no effect on muscle mass or 
strength. Based on the above-mentioned studies it appears to be a leucine ”trigger” at 
>2 g of leucine, causing a potent MPS-response in the first hours after ingestion. The 
prolonged effect of leucine stimulation in muscle is, however, less clear. 
 
2.10. Gender differences 
In the post absorptive state there appears to be no difference in MPS between young 
men and women (Smith et al, 2012; West et al, 2012). This also appears to be the case 
after isolated protein intake (Smith et al, 2009), RE (Dreyer et al, 2010), and when RE 
and protein intake are combined (West et al, 2012). Chevalier et al (2012) reported no 
differences in MPS between young and elderly women in the post absorptive or 
postprandial state. There also appears to be no difference in MPS between young and 
elderly men in the post absorptive state (Cuthbertson et al, 2005). In contrast to 
Chevalier et al (2012) findings, Smith et al (2012) reported increased MPS in elderly 
women compared to both elderly men and young women in the post absorptive state. 
Furthermore, Smith et al (2012) reported a blunted response to nutritional stimuli 
similar in both old women and men compared to their younger counterparts. The 
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reason for discrepancies between these studies (Chevalier et al, 2012; Smith et al, 
2012) could be attributed to the leucine plasma concentration being raised 250% 
above basal values in Chevalier et al (2012), while in Smith et al (2012) it was only 
raised 40% above basal values. If these discrepancies could be attributed to protein 
intake, it seems that elderly women might need larger protein boluses (>30 g) to 
robustly stimulate MPS.  
 
Elderly men has been shown to not benefit from larger protein doses compared to 
their younger counterparts (Cuthbertson et al, 2005), while other show a dose-
response relationship with whey-intake ranging from 20-40 g (Yang et al, 2012a&b). 
Furthermore AAT expression after RE seem to be unrelated to both age and gender 
(Drummond et al, 2011). In summary there appears to be no obvious gender-
differences in elderly men and women, but elderly women is reported to exhibit 
slightly increased post absorptive MPS and a slightly reduced response to protein 
intake compared to elderly men. 
 
2.11. Summary 
In summary, absorption kinetics, digestion, amino acid transport and basal MPS 
seems to be similar in both the young and old (Koopman et al, 2009; Drummond et al, 
2011; Reidy et al, 2014; Dickinson et al, 2014; Moore et al, 2015). Elderly seem to 
maintain the ability to respond to both exercise and protein intake, but special 
attention to increased protein intake (>20 g protein >15 g EEA>2 g leucine) and 
protein source seems important to maximize MPS (Cuthbertson et al, 2005; Katsanos 
et al, 2006; Tang et al, 2009; Yang et al, 2012a&b; Moore et al, 2015). Timing of 
intake seems to be of less importance (Kim et al, 2015). The reduced anabolic effect 
of lower doses of protein (< 20 g) can be restored by increasing leucine content 
combined with rapidly digested protein sources (e.g. whey) (Katsanos et al, 2006, 
Yang et al, 2012a&b).  
 
Furthermore, if RE precedes protein intake, there is a widening of the muscle full 
concept (Atherton et al, 2010) with an additive effect of the two stimuli in elderly, 
allowing for more dietary protein to be incorporated into skeletal muscle (Pennings et 
al, 2011; Yang et al, 2012a&b). Allowing more dietary protein to be incorporated into 
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skeletal muscle before MPS-response becomes refractory seems to be dose-dependent 
and not relying on delivery-profile, e.g. bolus vs spread feeding (Mitchell et al, 2015). 
As elucidated, greater training volumes of RE, increasing protein intake and select 
choice of protein source, independent of gender, seems to be promising strategies to 
overcome the anabolic resistance reported in the elderly (Cuthbertson et al, 2005; 
Katsanos et al, 2005; Kumar et al, 2009; Fry et al, 2011). Our study is highly relevant 
as it is of interest to examine whether full-body RE combined with habitual 
supplementation of native whey will induce greater hypertrophy and strength-gains 
compared to milk after 11 weeks. Furthermore, it is of interest to examine whether 
our exercise protocol and supplements could be efficient countermeasures to anabolic 
resistance. 
 
3. Intracellular signaling 
For external stimuli such as RE and protein intake to have anabolic effects, it must 
somehow be sensed and translated into anabolic signaling, increasing MPS for 
compensatory hypertrophy. The central mediator of external anabolic stimuli into 
anabolic internal signaling cascades is the serine/threonine kinase, mammalian target 
of rapamycin (mTOR) (Baar&Esser, 1999; Terziz et al, 2008; Fujita et al, 2007b). On 
its own, mTOR has a limited kinase activity, but form complexes with other proteins, 
dictating its location, activity and downstream effectors (Hara et al, 2002). Two main 
complexes of mTOR are formed, with either the rapamycin-sensitive raptor 
(mTORC1) or rapamycin-insensitive rictor (mTORC2) (Loewith et al, 2004). 
 
3.1. mTORC1 
It is widely accepted that in skeletal muscle, the rapamycin-sensitive mTORC1-
complex (from now on referred to as mTOR) is the main mediator of anabolic stimuli 
such as mechanical-loading (exercise) (Hornberger et al, 2007; Drummond et al, 
2009) and nutrient signaling (amino acids) (Atherton et al, 2010; Dickinson et al, 
2011). When administering the mTOR-inhibitor rapamycin, hypertrophy was 
abolished in skeletal muscle, and genetic activation of mTOR in a PI3K/Akt-
dependent manner, caused hypertrophy in vivo (Bodine et al, 2001). This was the first 
report of this matter, and led to the conclusion that mTOR-activation is both 
necessary and sufficient to induce hypertrophy (Bodine et al, 2001). Since growth 
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factors such as IGF-1 can activate PI3K/Akt, and Akt could affect a variety of mTOR-
independent growth regulatory molecules, it has been proposed that mTOR may be 
only permissive to induce hypertrophy (Goodman et al, 2010). Goodman et al (2010) 
shed light on this by overexpressing Rheb (mTOR-activator), activating mTOR in an 
PI3K/Akt-independent manner, showing mTOR to be both necessary and sufficient to 
induce hypertrophy in skeletal muscle. 
 
Furthermore, Hornberger et al (2007) used PI3K-inhibitor wortmannin, and showed 
mTOR-activation from mechanical loading to be PI3K/Akt-independent and 
rapamycin-sensitive. This was also confirmed in another study were Drummond et al 
(2009) used rapamycin, which blocked contraction-induced activation of mTOR, 
p70S6K and eEF2. Rapamycin-administration completely blocked the MPS-response, 
p70- and 4E-BP1 phosphorylation after ingestion of 10 g of EEA, showing the 
essential role of mTOR in mediating the anabolic stimuli of EEA (Dickinson et al, 
2011).  
 
A key PI3K-dependant upstream regulator of mTOR is a heterodimer consisting of 
TSC1 and TSC2 (Sancak et al, 2010). Growth factors and insulin signals through 
PI3K/Akt where TSC1/2 subsequently functions as a GTPase-activating binding 
protein for Rheb. GTP-bound Rheb interacts with mTOR and strongly stimulates its 
kinase activity. TSC1/2 negatively regulates mTOR by converting Rheb into it 
inactive GDP-bound form (Sancak et al, 2010). As RE and protein intake act in a 
PI3K/Akt-independent manner (Hornberger et al, 2007; Deldicque et al, 2008; 
Atherton et al, 2010; Dickinson et al, 2011) these anabolic stimuli activate mTOR by 
different mechanisms than through the growth factor/insulin-receptor PI3K. Growth 
factor/insulin-activation of mTOR ends with removing TSC1/2 from Rheb, a final 
step that is shared by mechanical loading (Jacobs et al, 2013).  
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3.2. Resistance exercise regulating mTOR 
The exact mechanism of mechanical-load transduction into increased mTOR-
activation remains elusive, but increased Rheb-activity (Jacobs et al, 2013) and 
increased [phosphatic acid] (PA) are possible explanations (Hornberger et al, 2007; 
You et al, 2014). Even though growth factor/insulin- and RE-induced-activation of 
mTOR share the final step (Sancak et al, 2010; Jacobs et al, 2013), RE seem to 
activate mTOR independently of PI3K/Akt (Hornberger et al, 2007; Deldicque et al, 
2008; Hulmi et al, 2009). Hornberger et al (2007) proved that mechanical stretch 
activated mTOR concomitant with PI3K/Akt inhibition by wortmannin. Furthermore, 
Figure 3.1: Simplified overview of suggested signaling pathways regulating MPS in skeletal muscle. 
Studied signaling proteins p70S6K, 4E-BP1 and eEF2 are highlighted with a yellow line. Green boxes 
indicate positive regulators of MPS and red boxes indicate negative regulators of MPS. 
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RE is shown to activate mTOR while Akt-activation decreases (Deldicque et al, 2008; 
Dreyer et al, 2006; Coffey et al, 2005; Hulmi et al, 2009). Thus, it seems while both 
growth factors/insulin and RE activate mTOR by removing TSC1/2 from Rheb, they 
do so from different upstream regulators. A distinct upstream regulator, sensing 
mechanical stimuli is yet to be identified, but some possible explanations are reported 
(Hornberger et al, 2007; You et al, 2014). 
 
One kinase that could be responsible for loading-induced mTOR-activation is 
diacylglyserol kinase zeta, an isoform of DGK (You et al, 2014). DGK-zeta can 
synthesize PA, which again is suggested to activate mTOR by direct binding to the 
FKBP12-rapamycin-sensitive site on mTOR, possibly competing with inhibiting 
effectors (You et al, 2014). On that note, this was only proved in vitro, in muscles 
from mice where DGK-knockout mice did not synthesize as much PA as wild-type 
mice, and increasing DGK-content combined with mechanical stretch further 
activated mTOR (You et al, 2014). Since absolute activation of mTOR remained 
unchanged compared to wild-type mice, the role of DGK can only be said to be 
modulating and not necessary for loading-induced activation of mTOR (You et al, 
2014). Another suggested synthesizer of PA is PLD, which has been shown in vitro to 
be activated by mechanical loading, thus increasing PA (Hornberger et al, 2007). 
 
3.3. Amino acid regulation of mTOR 
As previously elucidated, RE and protein intake has an additive effect on MPS. 
Allowing such an additive effect when combining these stimuli, EEA (especially 
leucine) regulate mTOR by different mechanisms than growth factor/insulin and RE 
(Kim et al, 2008; Sancak et al, 2008; Sancak et al, 2010). In absence of amino acids, 
mTOR is dispersed throughout the cytoplasm (Sancak et al, 2008). However, when 
amino acids are added, mTOR and Rheb relocalizes to the lysosomal membrane 
(Sancak et al, 2010). The importance of this lysosomal localization of mTOR and 
Rheb seems to be attributed to the additional regulators called Ragulator and the Rag-
family of small proteins (Sancak et al, 2008; Sancak et al, 2010).  
 
These amino acid specific regulators of the mTOR-pathway (Rag-family) exist as 
heterodimers with GTP-bound Rag A or B bound to GDP-bound Rag C or D, with 
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A/B and C/D being highly similar to each other, and functionally redundant (Sancak 
et al, 2008). Amino acids GTP-load RagA/B which binds to mTORs regulatory 
complex Raptor, and subsequently translocates mTOR to the lysosomal membrane, 
where Rheb is situated (Sancak et al, 2008). This regulatory role has been proven by 
Rag-knockdown and by overexpressing negative Rags (GDP-loaded), which 
suppresses amino acids effect on TOR-activity (in Drosophila cells) (Kim et al, 2008). 
When localized at the lysosomal membrane mTOR interacts with the Ragulator 
complex, which then recruits GTP-activated Rags, creating proximity to Rheb, thus 
activating mTOR (Sancak et al, 2010). Amino acids seem to have an essential role in 
enhancing growth-factor/insulin and resistance-exercise-induced stimuli because of 
this relocalization of mTOR to the lysosomal membrane, makin mTOR more readily 
activated (Sancak et al, 2008; Sancak et al, 2010).  
 
3.4. Translation initiation and elongation 
A central step in MPS is translation initiation (Bodine et al, 2001; Wang&Proud, 
2008). Translation initiation consists of a series of events for ribosomal complex 
assembly and binding of mRNA. Multiple initiation factors and signaling molecules 
regulate the formation of the translational apparatus and provide a highly dynamic 
and tightly regulated control of protein synthesis (Bodine et al, 2001; Wang&Proud, 
2008). This tight and dynamic regulation is evident as exercise and protein intake has 
shown signaling molecules and initiation factors to respond within minutes (Bolster et 
al, 2003). RE and protein intake induce translation initiation through phosphorylation 
of mTOR and sequential phosphorylation of key downstream-effectors p706SK and 
4E-BP1 (Cuthbertson et al, 2005; Kumar et al, 2009; Drummond et al, 2008; 
Dickinson et al, 2011; Farnfield et al, 2012). Further downstream, the sequential 
phosphorylation of mTOR-p706SK dephosphorylates (activates) elongation factor 2 
(eEF2) and enhances translation elongation (Fujita et al, 2007b).  
Downstream-effectors p70S6K and 4E-BP1 is phosphorylated by mTOR and 
influence translation initiation through distinct classes of mRNA (Wang&Proud, 
2008). Phosphorylated p70S6K subsequently phosphorylates ribosomal protein S6 
(rpS6), allowing efficient translation of mRNAs containing oligopyrimidine tracts in 
their 5’ untranslated regions (Burnett et al, 1998). In its dephosphorylated state, eIF-
4E binding protein (4E-BP1) binds to eIF4E, blocking its ability to form functional 
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interactions with eIF4G, which further interacts with eIF4A (Burnett et al, 1998). 
When 4E-BP1 is phosphorylated it releases from eIF-4E, allowing the eIF-4E/G/A-
complex to assemble and initiate cap-dependent initiation (Burnett et al, 1998). The 
activity of eukaryotic elongation factor 2 (eEF2) is regulated through reversible 
phosphorylation at the Thr56-residue by eEF2 kinase (eEF2K) (Wang et al, 2001). To 
increase both translation initiation and elongation, thus increasing translation 
efficiency, p706SK phosphorylates eEF2K (inhibiting its kinase activity) which 
subsequently leads to dephosphorylating (activating) of eEF2 (Wang et al, 2001). 
Activated eEF2 binds to the ribosomes and promotes the GTP-dependent 
translocation of the nascent protein chain from the A-site to the P-site of the ribosome 
(Wang et al, 2001). 
 
3.5. p706SK 
Activation of mTOR is often evaluated by measuring changes in the phosphorylation 
of the Thr389 residue of the 70Kda-isoform ribosomal S6 kinase (from now on 
referred to as p70, and activated p70 is phosphorylated at Thr389, unless stated 
otherwise) (Burnett et al, 1998; Hornberger et al, 2007; Sancak et al, 2008). Burnett et 
al (1998) showed phosphorylation of the Thr389 residue to be crucial for p70-
activation in vivo. Hornberger et al (2007) reported mechanical activation of p70 to be 
PI3K-independent and rapamycin sensitive in mice skeletal muscle cells. 
Furthermore, Baar&Esser (1999) reported that an initial post-exercise measurement of 
p70-phosphorylation correlated with subsequent hypertrophy in rats, and this is also 
reported after 14 weeks of resistance training in young men (Terziz et al, 2008). The 
degree of p70-phosphorylation after the initial exercise bout were highly correlated to 
the percentage increase in whole-body- and leg fat-free mass (FFM), 1RM squat and 
mean muscle cross sectional area (CSA) (Terziz et al, 2008).  
 
Fry et al (2011) reported that 0, 3, 6 and 24 hours after RE there were no significant 
changes in p70 and 4E-BP1 phosphorylation in elderly, with increased 
phosphorylation seen in their younger counterparts. The lack of significant changes in 
p70- and 4E-BP1-phosphorylation in elderly was mirrored by a blunted MPS-
response (Fry et al, 2011). This age-related blunted MPS-response, p70- and 4E-BP1-
phosphorylation was also confirmed in elderly by Kumar et al (2009) 0, 1, 2 and 4 
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hours post-exercise at 60-90% of 1RM, in the post absorptive state. In their younger 
counterparts, p70-phosphorylation 1 hour post-exercise was highly correlated with 
MPS-response within the same timeframe (1-2 hours).  
 
In contrast to these findings (Fry et al, 2011, Kumar et al, 2009), others did not find 
any age-related blunting of MPS- or intracellular signaling-responses (Farnfield et al, 
2012). When combining RE and protein intake in untrained participants, Farnfield et 
al (2012) reported a greater p70-phosporylation in elderly compared to young. 
Comparing the latter studies, RE without subsequent protein intake had a blunted 
response in elderly (Fry et al, 2011; Kumar et al, 2009), but when exercise was 
followed by protein intake this blunted response was diminished (Farnfield et al, 
2012). 
 
Protein intake with leucine in particular, is shown to be a potent regulator of p70 as 
supplementing a sub-optimal dose of 6.25 g whey with 3 g leucine showed similar 
activation of p70 as 25 g of whey; both under rested conditions and 1-3 hours post-
exercise (Churchward-Venne et al, 2012). Isolated leucine-intake has a potent effect, 
as 2 weeks of supplementing elderly with leucine (4 g/3 meals per day) improved 
both post absorptive and postprandial p70-phosphorylation, mirrored by a similar 
increase in MPS (Casperson et al, 2012). It should also be noted that Casperson et al 
(2012) did not supplement leucine on testing-days pre- and post-intervention that 
could confound these findings.  
 
The importance of post-exercise protein intake is emphasized as resistance training 
alone is shown not to phosphorylate p70 (Karlsson et al, 2004; Reitelseder et al, 
2011). When ingesting 0.1 g/kg body weight of branched-chained amino acids 
(BCAA) (45% leucine, 30% valine, and 25% isoleucine) p70 was profoundly 
phosphorylated 2 hours post-exercise (Karlsson et al, 2004). In contrast to the above 
findings ( Karlsson et al, 2004; Reitelseder et al, 2011), Terziz et al (2010) reported 
significant p70-phosphorylation after RE without subsequent protein intake. This has 
also been confirmed by Dreyer et al (2006) who reported increased p70-
phosphorylation 0, 1 and 2 hours after RE, with participants remaining in the post 
absorptive state the whole time period. Furthermore, the degree of p70 
phosphorylation in relation to exercise alone seems to depend upon training volume 
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with increasing phosphorylation at higher training volumes (Terziz et al, 2010). When 
examining different exercise intensities it seems that in the range of 60-90% of 1RM, 
the MPS-response and intracellular signaling-responses reaches a plateau in both 
young and old (Kumar et al, 2009).  
 
In addition to the potent effect of protein intake and leucine-content (Tang et al, 2009; 
Churchward-Venne et al, 2012; Karlsson et al, 2004), feeding pattern seems to affect 
intracellular signaling (West et al, 2011). To mimic a slower digested protein (e.g. 
casein) and to avoid protein source and leucine-content as confounding variables, 
West et al (2011) compared bolus vs spread intake (mimicking casein) of 25 g whey, 
and reported superior MPS- and intracellular signaling-responses to bolus-feeding. 
Both in the early (1-3 hours) and late (3-5 hours) postprandial period, bolus intake 
showed superior MPS-response, in concert with increasing p70-phospohyralation 
(West et al, 2011). Furthermore, spread intake increased MPS by 42% and 121% from 
baseline in the early and late postprandial period respectively, but no effect was seen 
on p70-phosphorylation in either period (West et al, 2011). 
 
Training status seem to influence acute p70-phosphorylation as Coffey et al (2005) 
compared endurance-trained vs strength-trained men, with only the endurance-trained 
increasing acute p70-phosphorylation post RE, in contrast to the data reported in 
resistance-trained in another study (Terziz et al, 2008). Furthermore, Farnfield et al 
(2012) found training status to be predictive of p70-phosphorylation. A bout of RE 
with subsequent intake of 26.6 g of whey (3.6 g leucine) or placebo was performed 
before and after an intervention of 12 weeks of resistance training in both young and 
elderly participants (Farnfield et al, 2012). In the untrained state (pre-intervention) 
both young and old increased p70-phosphorylation with whey compared to placebo 2 
hours post-exercise, but a greater phosphorylation was seen in the elderly. However, 
in the trained state (post-intervention) only the young participants maintained this 
p70-phosphorylation response to the exercise-bout and subsequent protein intake, 
with the elderly showing a blunted response in p70-phosphorylation. Regardless of 
p70-phosphorylation responses, both young and elderly had similar increases in 1RM 
strength after 12 weeks of RE (Farnfield et al, 2012). 
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Table 3.1: Overview of studies examining the effect of resistance exercise (RE) and/or protein intake on phosphorylation 
of p70, 4E-BP1 and eEF2. +* indicate significant increase. -* indicate significant decrease. = indicate no change. (+) or 
(-) indidcate a tendency of change. All biopsies were collected from m. vastus lateralis 
Authors Design Participants Intervention Signaling 
proteins 
Outcome measures 
Terziz et al, 
2008 
RCT 12 young RE-bout before 14 
weeks of resistance 
training. Leg press, 
6X6RM, 2 min rest 
between sets. Baseline 
biopsy in postprandial 
state. 
 
p-p70 
p70-phosphorylation was significantly increased 
30 minutes after initial RE-bout. The magnitude of 
p70-phosphorylation were highly correlated with 
subsequent increases in 1RM strength, whole body 
fat free mass and leg fat free mass after 14 weeks 
of resistance training. 
Farnfield et al, 
2012 
RCT 16 young 
18 old  
Acute day pre/post 12 
week RE. 26,6 g of 
whey-protein (3,6g 
leucine)/placebo after 
acute RE-bout. Biopsy 2 
hours after RE-bout 
 
 
 
p-p70 
p-4E-BP1 
 
p-p70 
p-4E-BP1 
 
Young 
Pre 
Whey         Placebo 
  (+)                 = 
  (+)                 = 
Post 
  (+)                 = 
  (+)                 
Old 
Pre 
Whey             Placebo 
   +*                    = 
   +*                    + 
Post 
   (+)                    =       
   +*                     = 
Moore et al, 
2011 
CT 7 young RE in post absorptive 
state. Unilateral leg-
press and knee-
extension. 25 g of whey 
immediately post-RE 
 
 
p-p70 
p-4E-BP1 
p-eEF2 
Whey 
1h            3h          5h 
 +*            =            = 
 +*            +*          +* 
 =              =            = 
 
RE + whey 
   1h            3h          5h 
   +*            +*          +* 
   +*            +*          +* 
   =              =            = 
Fujita et al, 
2007b 
RCT 14 young men 
 
Control (n = 7) 
 
EEA (n = 7) 
Fasted baseline biopsy. 
20 g of EEA with 7 g 
leucine at rest. Control 
group not consuming 
nutrients.  
 
 
p-p70 
p-4E-BP1 
p-eEF2 
EEA 
1 h 
+* 
+* 
-* 
Control 
1 h 
= 
= 
= 
Hulmi et al, 
2009 
RCT 18 young men. 
Protein  
(n = 9) 
 
Placebo  
(n= 9) 
15 g of whey /placebo 
before/after RE-bout. 
Total of 30 g whey (3.4 
g leucine) 
 
 
p-p70 
p-4E-BP1 
p-eEF2 
Whey 
    1 h              48 h 
     +*                 = 
     =                   = 
     =                   = 
 
Placebo 
 1 h          48 h 
        (+)              = 
        (-)               = 
         =                = 
 
Kumar et al, 
2009 
RCT 25 young 
 
25 old 
Post absorptive state. 
Unilateral knee-
extension and –
flexion. 60-90% of 
1RM data presented. 
 
 
 
p-p70 
p-4E-BP1 
p-eEF2 
Young 
10 min   1h     2h    4h 
      =       +*       =     = 
     (-)      +*       =    = 
     (-)      +* 
Old 
10 min   1h     2h    4h 
     =        =        =      = 
    (-)      (-)        =     = 
    (-)      +* 
Drummond et 
al, 2008 
RCT 7 young men, 6 
old men 
Post absorptive knee-
extension RE. 20 g of 
EEA (7g leucine) 
immediatley post RE 
 
 
p-p70 
p-4E-BP1 
p-eEF2 
Young 
1 h           3 h        6 h                     
 +*            +*        (+) 
(+)            +*         +* 
(-)             -*          -* 
Old 
1 h     3 h         6 h                     
+*             +*         +* 
(+)            +*        (+) 
(-)             -*          -* 
Dreyer et al, 
2006 
RCT 11 participants, 
both genders 
RE in fasted state. 
Biopsies before, 0, 1 and 
2 hours after RE 
 
p-p70 
p-4E-BP1 
p-eEF2 
0 hour 
(+) 
-* 
(+) 
1 hour 
(+) 
(-) 
-* 
2 hours 
+* 
= 
-* 
Dreyer et al, 
2008 
Cross-
over 
16 young men 
 
Control (n = 8) 
 
EEA (n = 8)  
RE-bout. EEA intake 1 h 
after RE. Control group 
did not consume 
nutrients. 
 
 
p-p70 
p-4E-BP1 
p-eEF2 
      0 hour 
     Control 
+* 
-* 
(+) 
      1 hour 
     Control 
+* 
= 
-* 
       2 hours 
       Control 
+* 
= 
-* 
 
p-p70 
p-4E-BP1 
p-eEF2 
EEA 
+* 
-* 
(+) 
EEA 
+* 
= 
-* 
EEA 
+* 
+* 
-* 
Dreyer et al, 
2010 
RCT 17 young, 9 
men, 8 women 
Fasted RE. 10X10 knee-
extension. Intensity was 
~67 % of 1RM. biopsy 1 
and 2 hours post-RE 
 
 
p-p70 
p-4E-BP1  
p-eEF-2 
1 h 
Men                Women 
   +*                      +* 
   =                        = 
   -*                       -* 
2 h 
Men                Women 
   +*                      +* 
   =                        = 
   -*                       -* 
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The anabolic effect of combining RE and protein intake has been shown to translate 
into increased intracellular signaling (Hulmi et al, 2009; Moore et al, 2011). Moore et 
al (2011) had their participants perform unilateral leg-press and knee-extension until 
failure and 25 g of whey protein was ingested immediately post-exercise, with the 
rested leg acting as a control. At 1, 3 and 5 hours post-exercise, both MPS and p70-
phosphorylation were increased and highly associated in the exercised leg, whereas in 
the rested leg, MPS and p70-phosphorylation only increased 1 hour post-workout, 
returning to baseline values after 3 and 5 hours (Moore et al, 2011). Hulmi et al 
(2009) reported that only when a total of 30 g whey protein were ingested in 
combination with RE there was a potent effect on p70-phosphorylation compared 
with exercise and non-caloric placebo. 
 
In contrast to studies showing p70-phosphorylation in concert with both hypertrophy 
(Baar&Esser, 1999; Terziz et al, 2008) and MPS-response (Moore et al, 2011; West et 
al, 2011), there appears to be a dissociation between single point-in-time changes in 
signaling molecule phosphorylation and the dynamic changes in MPS (Atherton et al, 
2010; Mitchell et al, 2015; Greenhaff et al, 2008; West et al, 2011). Atherton et al 
(2010) reported that both p70- and 4E-BP1-phosphorylation (baseline after 2.5 hours) 
outlasted the MPS-response (baseline after 1.5 hours). When bolus vs spread protein 
intake at rest were examined, there were no differences in MPS-response, but p70-
phosphorylation was greater with bolus feeding, explained by a more rapid 
aminoacidemia and leucinemia (Mitchell et al, 2015). A similar study (West et al, 
2011) had a greater MPS-response with bolus feeding compared to spread, but in 
contrast to Mitchell et al (2015), West et al (2011) reported increased p70-
phosphorylation and MPS to be highly associated after bolus feeding, but dissociated 
after spread feeding, as MPS increased concomitant with unchanged p70-
phosphorylation. This dissociation has also been confirmed by Greenhaff et al (2008) 
who saw a dose-response relationship between amino acid availability, p70-
phosphorylation and eEF2-dephosphorylation (activation), without concurrent 
changes in MPS. Churchward-Venne et al (2012) also reported a discrepancy between 
MPS and intracellular signaling as p70-phosphorylation was associated with leucine-
intake, but not MPS.  
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3.6. 4E-BP1 
Activating eukaryotic initiation factor 4E-binding protein 1 (4E-BP1) in vivo is 
reported to occur in a two-step mechanism (Gingras et al, 1999). The two 
phosphorylation-sites Thr37&46 are phosphorylated by mTOR, but do not disrupt the 
binding of 4E-BP1 to eIF4E, thus not allow for cap-dependent translation to initiate 
(Gingras et al, 1999). Thr37&46-phosphorylation serves as a prerequisite for 
subsequent phosphorylation of Thr70 to completely disrupt the 4E-BP1-eIF4E-
interaction, allowing the formation of initiation-complex eIF4E/G/A (Gingras et al, 
1999).  
 
RE is reported to decrease 4E-BP1-phosphorylation when protein is not supplemented 
(Deldicque et al, 2008; Dreyer et al, 2006; Hulmi et al, 2009). After an exhausting 10 
rep x 10 set leg-extension bout in the post absorptive state, biopsies were withdrawn 
30 seconds post-workout, with significantly decreased 4E-BP1 Thr37/46-
phosphorylation, whereas p70-phosphorylation was increased 20-fold (Deldicque et 
al, 2008). Hulmi et al (2009) reported decreased 4E-BP1 Thr37/46-phosphorylation 1 
hour after RE without subsequent protein intake. When 15 g of whey protein was 
ingested pre- and post-exercise this decrease was avoided and remained at baseline 
values, with authors (Hulmi et al, 2009) concluding this probably allowed for an 
increase in translation initiation. Dreyer et al (2006) reported similar findings after RE 
in the post absorptive state. 4E-BP1 Thr37/46-phosphorylation was decreased 
immediately after exercise slowly returning to baseline within the next 2 hours 
(biopsies withdrawn at 1 and 2 hours post-exercise) (Dreyer et al, 2006). In elderly, 
4E-BP1 remained unchanged 3 and 6 hours after RE in the post absorptive state (Fry 
et al, 2011). When RE was followed by 25 g of whey protein, 4E-BP1 Thr37/46-
phosphorylation was elevated 1, 3 and 5 hours post-exercise, but with no difference 
between the exercised and rested leg (Moore et al, 2011, further details in p70-section 
above).  
 
Examining the effect of training status, an intake of 26.6 g of whey (3.6 g leucine) or 
placebo was performed post-exercise, in both the untrained state (pre-intervention) 
and trained state (post-intervention) (Farnfield et al, 2012, for more details see 
description above in the p70-section). Only the elderly increased 4E-BP1 Thr37/46-
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phosphorylation with whey compared to placebo 2 hours post-exercise in the 
untrained state, and a greater phosphorylation was seen in the elderly in the trained 
state (Farnfield et al, 2012). Regardless of 4E-BP1-phosphorylation responses, both 
young and elderly had similar increases in 1RM strength after 12 weeks of resistance 
training (Farnfield et al, 2012). 
 
The potent effect of leucine was reported by Casperson et al (2012) with improved 
MPS both in the post absorptive and postprandial state, mirrored by increased 4E-BP1 
Thr 37/46 phosphorylation following 2 weeks of leucine-supplementation of 4 g/3 
meals per day. When a group of elderly ingested 10g of EEA post-exercise with either 
1.85 g (control-group) or 3.5 g of leucine (leucine-group), only the leucine group 
increased 4E-BP1 Thr37/46-phosphorylation 2 hours post-exercise (Dickinson et al, 
2014), emphasizing the potent effect of leucine-content. 
 
When examining the effect of different feeding patterns at rest, recent reports are 
contradicting (West et al, 2011; Mitchell et al, 2015). West et al (2011) reported 
increased 4E-BP1 Thr37/46 phosphorylation with no differences in bolus vs spread 
feeding of 25 g of whey, both in the early (1-3 hours) and late postprandial phase (3-5 
hours), despite increased MPS-response with bolus feeding. In contrast, Mitchell et al 
(2015) reported equal MPS with bolus vs spread feeding, but a greater 4E-BP1 
phosphorylation after bolus feeding. Examining different protein sources, Reitelseder 
et al (2011) reported a greater increase in 4E-BP1 Thr37/46-phosphorylation 1-6 
hours post-exercise with casein than whey, despite similar MPS-responses. These 
findings (Reitelseder et al, 2011; West et al, 2011; Mitchell et al, 2015) underline the 
fact that phosphorylation-pattern of key anabolic signaling proteins does not 
necessarily reflect MPS-response, also reported by others (Greenhaff et al, 2008; 
Churchward-Venne et al, 2012). 
 
3.7. eEF2 
Not being part of the initiation process, dephosphorylated eEF2 at residue Thr 56 
(activated) increases translation efficiency by enhancing translation elongation, thus 
contributing to an increased MPS (Fujita et al, 2007b). One hour after intake of ~20 g 
of EEA (~7 g of leucine) at rest, eEF2 was significantly dephosphorylated, with no 
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change seen in the control group not consuming nutrients (Fujita et al, 2007b). 
Furthermore there were significant increases in p70- and 4E-BP1 Thr37/46-
phosphorylation, and authors (Fujita et al, 2007b) concluded that EEA promoted MPS 
through translation elongation concurrently with translation initiation. Although Fujita 
et al (2007b) did not measure eEF2 kinase-activity directly, their data strongly suggest 
that the extraordinary large increase in p70-phosphorylation caused a subsequent 
dephosphorylation of eEF2. In contrast to these findings, Atherton et al (2010) 
reported that eEF2-phosphorylation remained unchanged for 6 hours following a large 
saturating bolus ingestion of 48 g whey protein. Also, after ingestion of 15 g of EEA, 
eEF2-phosphorylation was reported to be unchanged from fasting levels with both 
bolus and a spread feeding pattern (Mitchell et al, 2015). Furthermore, another study 
comparing bolus vs spread intake of protein (West et al, 2011) reported reduced 
eEF2-phosphorylation after spread-, but remained unchanged after bolus feeding. 
 
After RE, eEF2 is reported to be 20% less phosphorylated immediately post-workout, 
before rebounding to 120% of baseline values 1 hour post-workout, in both young and 
old in the post absorptive state (Kumar et al, 2009). Along with the previous study 
(Kumar et al, 2009), Moore et al (2011) also reported contradicting phosphorylation 
patterns of eEF2. A reduction in eEF2-phosphorylation was seen in the exercise and 
fed condition compared to rested and fed condition, but surprisingly with no change 
compared to rested and fasted condition (Moore et al, 2011).  
 
In contrast to the previous studies (Kumar et al, 2009; Moore et al, 2011), Dreyer et al 
(2006) reported decreased eEF2- and increased p70- and 4E-BP1-activation to be 
highly associated with MPS-response 1-2 hours post-exercise in the post absorptive 
state. Furthermore, after RE with a subsequent intake of 20 g of EEA (7 g leucine) 
both young and old had an equal MPS-response over 1-6 hours, with the elderly 
showing a delayed response (Drummond et al, 2008). Despite the delayed MPS-
response, elderly showed a similar tendency of reduced eEF2-phosphorylation as the 
young 1 hour post RE, and both age-groups showed a significant reduction 2 and 6 
hours post EEA-intake (Drummond et al, 2008). Others (Hulmi et al, 2009) reported 
unchanged eEF2-phosphorylation 1 hour after RE in combination with a total intake 
of 30 g of whey protein. In summary, studies show contradicting eEF2-
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phosphorylation patterns after RE and protein intake, with reports of decreased, 
increased and unchanged phosphorylation. 
 
3.8. Summary, intracellular signaling 
Theoretically, increased p70- and 4E-BP1-phosphorylation together with decreased 
eEF2-phosphorylation initiate translation initiation and elongation. After RE and 
protein intake, the phosphorylation-patterns of these signaling proteins are reported to 
be highly varied and greatly affected by time of biopsy-collection (table 3.1). 
Furthermore, the phosphorylation responses to the anabolic stimuli of RE and protein 
intake are highly influenced of whether these stimuli are combined or isolated, with 
the combined effect generally shown to be of greater effect. The magnitude in 
phosphorylation of the different signaling proteins seems to work in a dose-response 
relationship to RE-volume, and leucine-content and absorption rate of given protein 
sources.  
 
In general, p70-phosphorylation is reported to increase 0-6 hours after RE and protein 
intake, with elderly reported to have a delayed and/or blunted response compared to 
young. 4E-BP1-phosphorylation seem to be reduced 0-2 hours after RE, but is 
restored to/increased above baseline values after 2-5 hours when RE is combined with 
protein intake of >3.5 g leucine. Phosphorylation of eEF2 0-6 hours after RE and 
protein intake is reported to be greatly varied. The contradicting reports in eEF2-
phosphorylation response to RE and protein intake, has led to several authors question 
the physiological importance of the phosphorylation status of eEF2.  
 
This study is highly relevant, as it is of interest to examine whether native whey with 
increased leucine content and absorption-rate compared to milk-protein, enhance the 
phosphorylation responses of these signaling molecules. Furthermore, this study could 
further elucidate whether such an intracellular anabolic advantage would lead to 
increased hypertrophy and strength after 11 weeks of RE and native whey vs milk 
supplementation. 
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4. Method 
4.1. Overall study design 
This thesis is based from the results of a larger study. The study was conducted as a 
randomized double-blinded controlled intervention. The intervention was eleven 
weeks of strength training combined with protein supplementation of 40 g per day as 
native whey or milk protein in an elderly population above 70 years of age. The main 
goal of the study was to compare acute and long-term effects of native whey vs milk 
supplementation combined with resistance exercise (RE) on intracellular anabolic 
signaling and changes in muscle mass and strength. The study was ethically approved 
by the South-East Regional Ethical Committee of Norway. The Norwegian Research 
Council and Tine SA were joint funders of this study. None of the contributors to the 
completion of this study had any conflicting interests or relation to the funders of the 
study. 
 
Our participants went through extensive pre- and post-testing of both invasive and 
non-invasive manner. This has produced data on body composition, bone mineral 
density (BMD), upper- and lower-body 1RM strength, performance in daily living, 
recovery and intracellular responses. All resistance training and data collection were 
done at the Norwegian School of Sport Sciences (NSSS). The focus of this master 
thesis is on the acute intracellular hypertrophic responses downstream of mTOR, after 
RE combined with native whey vs milk supplementation. This RE-bout was 
completed before and after 11 weeks of RE, with the same group of participants (see 
acute study section), going from an untrained to a more trained state. Through biopsy-
collection pre- and post RE and protein intake, completed before and after the 11 
week intervention, I have been able to link acute phosphorylation patterns of key 
signaling proteins to long-term hypertrophy and strength gains. I have personally been 
involved in the entire process of this study, from recruitment, pre-testing, training, 
post-testing and subsequent analysis. Western blot analysis was performed at the 
laboratory of NSSS. The following method section will mainly be focused towards 
the acute part of the study, and methods most relevant to my analysis and personal 
involvement.  
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4.2. Recruitment and randomization of study subjects 
We recruited 30 participants above 70 years of age from both genders, unfamiliar 
with previous strength training. Participants were recruited through flyers, dialogue 
with several centers for elderly and advertisement in a local newspaper (appendix 1). 
To participate in the study we had pre-determined inclusion and exclusion criteria 
(table 4.1).  Upon contact, all participants received detailed information of potential 
risks from participating in the study. 
 
4.3. Screening 
After initial contact, all potential participants were called in for an interview and 
screening. This process revealed whether they were eligible for the study or not, based 
on the pre-determined criteria (table 4.1). The screening process also consisted of a 
preliminary testing day (further details are listed below). DXA-scan was performed to 
reveal bone mineral density (BMD) and body composition, a blood draw determined 
cholesterol levels, fasting glucose– and lipid-levels and measurement of blood 
pressure. After completing a yes/no questionnaire, participants adhering to all 
inclusion/exclusion criteria could begin the intervention. When in doubt we also got a 
doctor’s declaration of the given criteria to ensure eligible participants. All 
participants gave informed written consent before participating in the study (appendix 
2). 
 
 
 
 
 
Table 4.1: Overview of inclusion/exclusion criteria. All participants adhered to these criteria to 
participate in this study. 
Inclusion criteria Exclusion criteria 
- Men and women older than 70 years. 
- Able to attend training at NIH 3 days a 
week. 
- Able to read and speak Norwegian. 
- Not regularly participating in strength 
training. 
- Use of specified medicines and 
supplements. 
- Lactose intolerance and/or milk allergy. 
- Allergic to local anaesthesia. 
- Use of corticosteroids last 6 months. 
- Bone mineral density (BMD) below – 
0.84 g/cm2 in L2-L4. 
- Uncontrolled hypertension. 
- Heart attack last 6 months. 
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4.4. Randomization 
30 participants met our inclusion/exclusion criteria and were divided into two study 
groups that were supplemented with either native whey or milk (for supplement 
details, see nutrition section). The division into two groups was randomized, but 
stratified based on pre-intervention lean mass and gender (table 4.2). An individual 
not part of the physical testing nor any type of analysis was responsible for the 
randomization, stratification, and for concealing the group identity of each participant 
throughout the study. 4 participants withdrew from the study within the first 3 weeks, 
with the remaining 26 participants completing the entire intervention (completion of 
all tests and above 80% completion of all RE). 19 participants volunteered to be in the 
acute part of the study, 16 of these completed the study, making up the participant 
pool this thesis is based on (figure 4.1). Because of withdrawal from the study by 3 
participants the groups ended up slightly skewed based on gender and number of 
participants. 
 
 
 
Figure 4.1: Overview of the randomization process. Of the 26 participants completing this study, 16 
took part in the acute part of the study. NW group consisted of 9 participants (6 men and 3 women) and 
Milk group of 7 participants (3 men and 4 women). 
Total: n = 26 
 
Acute group:  
n = 16 
Men 
n = 9 
Native whey:  
n = 6 
Milk: n = 3 
Women:  
n = 7 
Native whey:  
n = 3 
Milk: n = 4 
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4.5. Preliminary testing 
For preliminary testing, all participants met in the fasted state (>8 hours) between 8 
AM and 10 AM at NSSS. All preliminary testing procedures were repeated at the end 
of the intervention to produce post-measurements in all participants. The project 
manager met up with each participant before a DXA-scan was performed and blood 
samples were withdrawn. After fasted blood samples, blood pressure and DXA-scan, 
participants could eat their first meal of the day (food choices was not restricted, and 
each participant brought their own food).  
 
After a 24 h recall nutrition interview and ultrasound of the m. vastus lateralis 
thickness, each participant was escorted to the school gym to perform 1RM-testing in 
leg press and chest press. 1RM-testing started with a 10 minute warm-up on either 
treadmill or stationary bike. Subsequently, several sub-maximal lifts with incremental 
loads were completed before 1RM were reached (further details in 1RM-testing 
sections below).  
 
DXA and ultrasound were used to measure changes in body composition, bone 
mineral density and muscle size. 1RM-testing in leg press and chest press reflected 
changes in maximal strength. Functional tests were chair raise and stair climb and 
served as measures of performance in activities of daily living. To measure our 
participant’s rate of force development (RFD), maximal voluntary contraction (MVC) 
were performed in a leg extension machine with a power gauge. MVC was conducted 
pre- and two times post-workout on acute days, and an additional time the following 
day. In this way MVC-testing served as a mean to reflect recovery after an exhausting 
10RM workout on acute days. For an overview of the preliminary testing day, see 
figure 4.2. 
 
39 
 
 
Figure 4.2: Overview of the preliminary testing day, starting with each participant meeting up with the 
project manager before subsequent testing procedures were completed. 
 
 
4.5.1. Ultrasound and nutrition interview 
Participants underwent ultrasound-scans of the thickness of m. vastus lateralis, with 
calculation of thickness based on the 3 best images. The coefficient of variation (CV) 
between the preliminary testing days for the subjects that underwent both ultrasounds 
scans included in the study was 2.23 %, out of 82 images. A Msc. student in clinical 
nutrition performed all 24 h recall interviews, and gave nutritional advice to 
participants. Participants were not allowed to have a total protein intake below 1.2 
g/kg body weight/day during the intervention period (protein content of given 
supplements included). 
 
4.5.2. 1RM-tests and functional testing 
1RM-testing started with a 10 minute general warm-up of each participant’s 
preference, either on a stationary bike (Technogym, Italy) or treadmill (Technogym, 
Italy, Woodway). Before maximal lifts were attempted, every participant would 
undergo an exercise-specific warm-up, with series of 10, 6 and 3 repetitions of 
progressively increasing weights lifted. 
 
Meeting the 
Project manager 
DXA 
Bloodsamples & 
Blood pressure 
Breakfast/lunch 
Ultrasound 
& nutrition 
interview 
1RM-Testing 
Functional 
testing 
Isometric MVC 
End of 
preliminary day 
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4.5.3. Leg press 
1RM leg press was performed in a leg press machine (Technogym, Italy). Participants 
were instructed to place both feet centered and to not allow knees falling medially 
inwards. Without added weight, the weight-sled was lowered to a 90 degree knee-
joint angle and an individually corresponding wooden pole (ranging from 18 to 36 
cm) was put underneath. This was to ensure correct individualized sled position and 
repeatability for all warm-up sets and 1RM-attempts. 1RM-attempts started from a 
completely extended knee-joint position. The weight was lowered in a controlled 
manner all the way down to the wooden pole (depth marker) assigned to each 
participant. Upon contact, participants pressed the weight-sled back to starting 
position (fully extended knee-joints). After a successful/unsuccessful lift, weight was 
added/removed or remained the same, and a new attempt was performed after 2 
minutes of rest. This process was repeated until 1RM was reached as a consequence 
of failure, or test supervisor deemed the participant’s technique to be of unsatisfactory 
manner (e.g. knees falling medially inwards). 
 
4.5.4. Chest Press 
1RM chest press was performed in a chest press machine (Technogym, Italy). Seat 
height and grip width (determined as narrow/medium/wide) was individualized. 
These settings were used at every test session to ensure repeatability. Participants 
were instructed to maintain contact with the back support under the entire lift and 
with their feet placed on the ground. All lifts started in a flexed elbow-joint position 
and a successful lift was when both arms reached a fully extended elbow-joint 
position. As with the leg press, weights were gradually increased until 1RM was 
reached as a consequence of failure or unsatisfactory technique. 
 
4.5.5. Functional tests 
1RM-testing was followed by functional tests. Participants performed a laser-timed 
stair-climb without and with added weight in the form of a 10 kg weight-west and two 
5 kg manuals in each hand. Each participant completed 3 tries (1 set) without added 
weight, before a subsequent set with a 10 kg weight-west followed by a last set with 
additional 5 kg manuals in each hand. The best try in each set was used in subsequent 
analysis. Afterwards, each participant went through a sit-to-stand test (five times up 
and down) measured with a pressure sensor with the best of 3 tries considered as their 
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final score. This was followed by an isometric MVC (MVC-details in acute study 
section).  
 
4.5.6. Baseline values 
All pre-tests of a physical 
character (MVC, 1RM and 
functional tests) were 
repeated after a few days of 
rest.  The best result achieved 
over these two days was set 
as baseline values before the 
intervention started. This was 
to ensure test familiarization 
and thus baseline values that 
best reflected their baseline 
condition at the start of the 
study. There were no significant (P>0.05) differences between groups (table 4.2).  
 
4.6. Eleven week resistance training protocol 
RE was performed with participants divided into groups of 3 individuals, and each 
training session was led by a personal trainer. This was to ensure appropriate weight 
and form was conducted throughout the workout. The training protocol consisted of 
whole-body workouts with a daily undulating periodization scheme (complete 
overview of training program, appendix 3). All exercises were performed in machines 
(Technogym, Italy) except for shoulder press, which was executed with free-weights. 
The choice of not using free-weights was based upon difficulties in learning 
appropriate form and technique, thus confounding strength gains with improvements 
in technique. Furthermore, the use of machines enhanced standardization of both 
training and testing, thus allowing weekly increases in weights lifted reflecting actual 
improvements in strength, and not technique.  
The training program was divided in 3 week mesocycles with a gradual increase in 
intensity and total training volume to avoid early over-training, and a continuous 
progression throughout the total 11 weeks of training. Participants exercised 
 Native whey 
N = 9 
Milk 
N = 7 
Gender ♂ = 6 / ♀ = 3 ♂ = 3 / ♀ = 4 
Age 72.2 (1.3) 74.7 (2.7) 
Body mass (kg) 79.6 (19.1) 74.5 (12.8) 
Lean mass (kg) 51.2 (12.3) 49.7 (6.5) 
1RM leg press (kg) 174.4 (63.3) 160.4 (35.5) 
1RM chest press (kg) 48.1 (20.0) 39.3 (12.0) 
Functional tests No significant differences 
(P>0.05) 
Table 4.2: Baseline values of the NW and Milk group. There were 
no significant differences between groups (P>0.05). Values are 
given as a mean ± (SD) 
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Mondays, Wednesdays and Fridays ensuring proper recovery and rest between 
workouts. 
 
4.7. Acute part of the study 
16 participants completed an acute day, pre- and post-intervention. This group 
underwent two biopsies (pre and post 10RM-workout) on both acute days (four 
biopsies in total) to investigate changes in intracellular signaling molecule 
phosphorylation patterns in the acute phase after an exhausting strength workout. This 
was done before the intervention started, and then repeated at the end of the 
intervention. On acute days we supervised their nutrition, training and recovery to 
ensure standardized test-circumstances. For a complete overview of acute days, see 
figure 4.3. 
 
 
 
 
4.7.1. Biopsies 
On acute days, two biopsies were obtained from m. vastus lateralis. The second 
biopsy was withdrawn with the biopsy-needle inclined at a different angle than the 
Figure 4.3: An example timeline showing an acute day with a participant consuming a standardized breakfast at NSSS 08:00. The 
specific time-points for biopsies and MVC are highlighted with red and green arrows, respectively. 10RM training bout and 
subsequent protein intake are highlighted in blue writing. 
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first biopsy, to ensure the second withdrawal was ~5 cm apart from the first. Biopsies 
were withdrawn under sterile conditions and with l% lidocaine local anesthesia. 
Professor Truls Raastad was responsible for all biopsies taken. The first biopsy took 
place 30 minutes before the 10RM workout started and the second biopsy was taken 2 
hours after the 10RM workout ended. The choice of these time points was based on 
previous studies, and was chosen to best reflect phosphorylation status of the studied 
signaling proteins. Muscle biopsies were obtained with a 6mm Bergstrom needle and 
vacuum pump, allowing suction to pull out maximum amount of muscle tissue (Evans 
WJ, Phinney SD, Young VR, 1982). About 150 mg of muscle tissue were collected at 
every biopsy. The tissue was divided to serve different subsequent analysis purposes, 
before frozen in liquid nitrogen and stored in an ultra-freezer (-80°C). 50 mg of 
muscle tissue was used for analysis of phosphorylation status of p706SK, 4E-BP1 and 
eEF2. 
 
4.7.2. Nutrition 
Nutrition on acute days was logged, and portion sizes given to each participant were 
based on gender, age and previously measured lean body mass. Participants met at 
NSSS fasted and were fed a standardized breakfast of oatmeal, water, oil, sugar and 
cinnamon. Immediately post-workout, a shake of native whey or milk (Prolacta®, 
Lactalis, France) protein was given and consumed by each participant (nutritional 
content and amino acid profiles, table 4.3).  
 
This shake was consumed two times per day throughout the entire intervention period 
by each participant. Shakes were consumed immediately post-workout and in the 
evening. On days without training, each participant was instructed to consume one 
shake with breakfast and the other in the evening. Native whey and milk sachets were 
isocaloric, and only amino-acid profile differed between supplements. Lunch on acute 
days was provided as God Morgen yoghurt with muesli after all tests were completed. 
Furthermore, each participant was provided with food for the remaining day 
(Fjordland, ready-made meals) and another oatmeal-breakfast to be consumed the 
following day at home, before returning for a follow-up MVC-test at NSSS 24 hours 
after the end of the workout. 
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4.7.3. Recovery 
MVC in m. Quadriceps femoris with right and left leg was measured individually 20 
minutes before the start of the workout and served as a baseline MVC value. This was 
repeated 15, 150 minutes and 24 hours after completion of 10RM workout. MVC was 
performed in a GYM 2000 knee-extension machine connected to a power gauge 
(HBM U2AC2, Darmstadt, Germany). The power gauge was connected to a PC and 
MVC was analyzed with Labview 8.2 (National instruments, Austin, Texas, USA). 
Individual back-, seat- and leg-settings were used for each participant at every MVC. 
Table 4.3: Table showing the amino acid profile, fat and carbohydrate content in native whey and 
milk. Doses were given as an individual sachet after the 10RM workout and two times per day 
throughout the 11 weeks of training. Essential amino acids are labeled with a *. 
Amino acids 
(g/100 g) 
Native whey Milk 
g/100g 
g per sachet  
(69 g) 
g/100g 
g per sachet 
(73 g) 
Alanine 1.3 0.9 0.9 0.7 
Arginine 0.8 0.6 0.9 0.6 
Aspartic acid 3.1 2.1 2.2 1.6 
Cysteine 0.7 0.5 0.2 0.2 
Phenylalanine* 1.2 0.8 1.3 1.0 
Glutamic acid 5.3 3.7 5.9 4.3 
Glycine 0.5 0.4 0.5 0.4 
Histidine* 0.7 0.5 0.8 0.6 
Isoleucine* 1.6 1.1 1.4 1.0 
Leucine* 3.4 2.3 2.7 2.0 
Lysine* 2.8 2.0 2.3 1.7 
Methionine* 0.7 0.5 0.7 0.5 
Proline 1.8 1.2 2.7 2.0 
Serine 1.4 1.0 1.5 1.1 
Threonine* 1.4 1.0 1.2 0.9 
Tyrosine 1.0 0.7 1.2 0.9 
Valine* 1.6 1.1 1.8 1.3 
Tryptophan* 0.6 0.4 0.4 0.3 
Total protein  27.7 19.1 27.3 20.3 
* Total EEA 14.0 9.7 12.6 9.3 
Total NEA 13.7 9.4 14.7 11.0 
Fat 10.3 7.1 10.0 7.3 
Carbohydrate 57.1 39.4 51.6 37.7 
Total calories 430.6 297.1 407.2 297.3 
45 
 
Participants performed two warm-up contractions with both legs, and were instructed 
to use approximately 25% and 75% of their maximum effort and contract for 5-10 
seconds. After warm-up, three maximum effort MVC on each leg was performed with 
every participant instructed to hold the contraction for 2-3 seconds, and as quickly as 
possible reach maximum power. Each leg had 1 minute rest between trials. 
 
4.7.4. 10RM workout 
30 minutes after the first biopsy was taken, 
each participant was individually led 
through a standardized 10RM workout with 
6 exercises of 3 sets of each exercise (table 
4.4), all completed to exhaustion. There 
were 3 lower body- and 3 upper-body 
exercises. Starting weight was based on 
previous 1RM results in leg-press and 
chest-press. If starting weight was set too 
low in a given exercise, weight was put on 
to achieve 10RM. A new set was started 
every third minute which made all workouts 
last approximately 51 minutes.  
 
4.8. Analysis 
4.8.1. Homogenization 
Muscle tissue from biopsies was contained in ultra-freezers at – 80°C until 
homogenization. Approximately 50 μg muscle tissue were homogenized with 1 ml T-
PER ® (Tissue Protein Extraction Reagent, Thermo scientific, Rockford, IL, USA), 
20 μl HaltTM Protease and Phosphatase Inhibitor Cocktail (Thermo scientific, 
Rockford, IL, USA) and 20 μl EDTA (Thermo scientific, Rockford, IL, USA). 
Homogenization was performed in pulses of 3-5 seconds until tissue was completely 
dissolved. After homogenization, samples were put at 4°C for 30 minutes. 
Subsequently, samples were centrifuged at 10 000 G for 10 minutes at 4°C. The 
supernatant from every sample were then transferred to 1.5 ml tubes before being 
centrifuged for another 10 minutes at 10 000 G. Afterwards, the supernatant were 
Table 4.4: Table showing all 6 exercises 
performed on acute days. Training load was 
10RM, and load was added for each set if sets 
were not exhausting. 
Exercise Sets  Reps Load 
Hammer squat 3 10 RM 
Leg press 3 10 RM 
Knee extension 3 10 RM 
Chest press 3 10 RM 
Seated row 3 10 RM 
Shoulder press 3 10 RM 
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aliquoted in labeled 0.2 ml tubes, each containing 25 μl, before being put in an ultra-
freezer at -80°C. 
 
4.8.2. Total protein measuring procedure 
To establish total protein content, RC/DC Protein Assay kit from BioRad was used 
(cat. no. 500-0121, Herkules, CA, USA). Standard proteins were bovine y-globulin, 
ranging from 0.125 to 1.5 μg/ml. Samples were diluted 1:4 to ensure that protein 
concentration were within the range of standard proteins used. Triplicates of 5 µl from 
each sample were pipetted into a 96-well microtiter plate (Greiner Bio-one 
International AG, Kremsmünster, Germany). After pipetting, 25 µl reagens A*S and 
200 µl reagens B were added in all wells. The wells were then sealed to avoid 
contamination and put in a dark closet for a minimum of 15 minutes. After 15 minutes 
the microtiter plate was analyzed in ASYS Expert 96 (Biochrom, Cambridge, UK). 
Only total protein measurements, with a CV<10% were used for subsequent Western 
Blot analysis, calculated with KIM Immunochemical Processing Software 32. 
 
4.8.3. Western Blot 
Resting levels and acute changes in the proteins of interest (eEF2, p706SK and 4E-
BP1) was determined with Western Blot analysis at the NSSS laboratory. These 
analyses derived from muscle tissue obtained with biopsies from the m. vastus 
lateralis. For my own complete step-by-step procedure, see appendix 4.  
 
4.8.4. Sample preparation 
0.2 ml tubes were used to mix buffer (5MDT and Laemmli sample buffer, BioRad, 
CA, USA), distilled deionized water (dH2O ) and muscle tissue samples, resulting in a 
total volume of 65 μl in each tube. 5MDT and Laemmli sample buffer (65.8 mM Tris-
HCl, pH 6.8, 2.1% SDS, 26.3% glycerol, 0.01% bromophenol blue) (diluted 1:14) 
were added in a total of 16 μl to each 0.2ml tube with the remaining volume made up 
of dH2O and tissue sample (calculations based on previous total protein 
measurements). Samples were then put on a heat block at 70°C for 10 minutes, before 
being applied on Criterion™ TGX (Tris-Glycine eXtended) Stain-Free™ precast 12-
well gels for PAGE (BioRad, CA, USA). Each well was applied with 30 μl sample, 
containing 45 μg protein content. Samples from two study subjects were applied on 
each gel. In the first and last well, 5 μl of Protein Marker PS11 (GeneOn, GmbH, 
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Germany) was applied to serve as a protein marker, ranging from 10-175 kDA (figure 
4.4). Each run included duplicates of each participant on a second gel. 
 
4.8.5. Electrophoresis 
Electrophoresis was done in a Mini-PROTEAN® Tetra Cell (BioRad, CA, USA), at 
200 V with a HC High-Current Power Supply (BioRad, CA, USA). Running buffer 
consisted of 10% Tris/Glycine/SDS #161-0732 (BioRad, CA, USA) and 90% dH2O. 
Electrophoresis continued until the GeneON-marker showed satisfactory separation of 
the 95 and 70 kDa bands (for separating eEF2 at ~90 kDa and p70 at ~70 kDa). 
Satisfactory separation was consistently achieved after 44-45 minutes. After 
electrophoresis, gels were put in a ChemiDoc
TM
 MP Imaging System from BioRad 
(Hercules, CA, USA). This step UV-activated (2.5 minutes) the gels and visualized 
protein distribution (figure 4.4).  
 
 
 
Figure 4.4: An example picture of UV-activation of two gels run as duplicates. Picture 
shows protein distribution after electrophoresis. The Gene-On-marker used for later cutting of 
membranes is shown to the right. 
 
4.8.6. Blotting 
Proteins were transferred to a PVDF-membrane (Cat#162-0177, Bio-Rad, CA, USA) 
in a Criterion
TM 
Blotter (BioRad, CA, USA), with transfer buffer consisting of 10% 
methanol, 10% Tris/Glycine (Cat# 161-0743, BioRad, CA, USA) and 80% dH2O. 
Blotting was run at 100V for 30 minutes with a magnet and ice pack inside the blotter, 
to ensure circulating transfer buffer, and avoid overheating.  
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After blotting, both gels and membranes were put in ChemiDoc
TM
 MP Imaging 
System to reveal transfer of proteins on duplicates, serving as a loading control 
(figure 4.5). This method of loading control has been proved superior to traditional 
methods using reference-proteins such as α-tubulin, ß-actin and GADPH (Vigelsø A, 
Dybboe R, Hansen CN, Dela F, Helge JW and Grau AG. 2015). 
 
 
 
4.8.7. Blocking and antibodies 
After blotting and imaging of protein transfer and total protein loading, the 
membranes were incubated (blocked) for 2 hours in a 5% skim milk solution. After 
blocking, each membrane was cut to separate eEF2, p70 and 4E-BP1 into strips (with 
the help of GeneOn protein marker, see figure 4.4). The different membrane strips 
Figure 4.5: Picture of the same duplicate gels (top) as in figure 4.4, and membranes (bottom) 
after blotting. Comparing figure 4.4 with the top two gels in fidure 4.5 one can clearly see how 
proteins has been transferred to their respective membranes (bottom) for further handling and 
analysis. 
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were then incubated in their respective primary antibodies for phosphorylated protein 
(overview of antibody specifics and chosen dilutions in table 4.5).  
 
Incubation was at 4°C over-night on a rocker-machine. The next day, membranes 
were washed for 15 minutes in TBS-T and 3 x 5 minutes in TBS (10X Tris Buffered 
Saline, Cat#170-6435, BioRad, CA, USA). TBS were 10-fold diluted giving 20 mM 
Tris, 500 mM NaCl, pH 7.4. TBS-T was the same formula with the adding of 1ml 
Tween 20 per litre of TBS-solution. After washing, membranes were incubated in 
secondary Anti-rabbit IgG HRP-linked antibody for 1 hour at room temperature, 
followed by another round of washing in TBS and TBS-T.  
 
Membranes were incubated in Cheliminescent Substrate SuperSignal® WestDura 
(Thermo Scientific, Rockford, IL, USA) for 5 minutes before imaging in 
ChemiDoc
TM
 MP Imaging. After imaging, membranes were stripped for 10 minutes 
in Restore
TM 
PLUS Western Blot Stripping Buffer (Thermo Scientific, Rockford, IL, 
USA) before another round of washing. After washing, membranes were blocked for 
2 hours in 5% skim milk, followed by subsequent incubation over-night at 4°C in 
primary antibodies for total protein content. The following day was similar to the day 
after the first over-night incubation and ended with imaging of total protein content. 
 
 
Table 4.5: Table showing all primary and secondary antibodies used,  with their respective dilutions. 
Primary antibodies were phospho- and total protein-specific. Secondary antibody used was Anti-rabbit 
IgG HRP-linked antibody 
Antibody Manufacturer Host Dilution Cat.nr 
P70S6 kinase Cell Signaling Rabbit 1:1000 #9202S 
Phospho p70S6 kinase (Thr 389) Cell Signaling Rabbit 1:1000 #9234S 
eEF2 Cell Signaling Rabbit 1:5000 #2332S 
Phospho eEF2 (Thr 56) Cell Signaling Rabbit 1:5000 #2331S 
4E-BP1  Cell Signaling Rabbit 1:1000 #9452S 
Phospho 4E-BP1 (Thr70) Cell Signaling Rabbit 1:1000 #9455S 
Anti-rabbit IgG HRP-linked antibody Cell Signaling Goat 1:3000 #7074S 
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4.9. Statistics 
 
All data are presented as means with standard deviation (±SD). In all figures in the 
following results-chapter, ±SD are indicated with error-bars. Pearson’s r  product 
moment correlation coefficient was used to explore the relationship between different 
variables. Student’s t-test for paired/unpaired observations was used to evaluate 
differences within/between groups in phosphorylation-status of p70S6k, 4E-BP1 and 
eEF2 pre- and post-workout. A one-way factorial ANOVA with repeated measures 
was employed to evaluate physiological, anthropometrical and performance changes 
before and after the intervention within the NW and Milk groups. P <0.05 was chosen 
as a two-tail level of significance. A two-way factorial ANOVA with repeated 
measures was employed to evaluate physiological, anthropometrical and performance 
changes before and after the intervention between NW and Milk groups. Calculations 
were done in Microsoft® Excel 2011 and Prism® 6 (GraphPad Software Inc., San 
Diego, CA, USA). 
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5. Results 
5.1. Resistance 
training volume 
There were no significant 
(P>0.05) differences between 
groups in resistance training 
(RT) volume (repetitions x 
series x intensity) on either of 
the two acute days (figure 5.1). 
RT-volume was significantly 
increased (P<0.0001) on acute 
day 2 compared to acute day 1 
in both groups. RT-volume 
increased by 69% ± 22 and 63% 
± 21 for the native whey (NW) 
and milk group respectively. 
The increase in RT-volume on 
acute day 2 was due to a higher training load as repetitions were set at 10 in each set. 
The greater albeit non-significant training volume (P>0.05) in the NW group on both 
acute day was mirrored by a greater (P=0.089) 1RM leg-press and chest-press pre and 
post-intervention (table 5.1).  
 
5.2. p70S6K 
Ratio of phosphorylated p70S6K (Thr 389) to total p70S6K was significantly 
increased (P<0.05) from baseline (pre-biopsy) in the NW and Milk group on acute 
day 2 (figure 5.2). On acute day 1 ratio of phosphorylated p70S6K (Thr 389) to total 
p70S6K increased in the Milk and NW groups but failed to reach significance 
(P>0.05) with (P = 0.0529) and (P = 0.0713), respectively. There was no significant 
(P>0.05) differences between groups on either of the acute days. No significant 
differences was found within either group when the response on acute day 1 was 
compared with acute day 2, although a tendency of greater p70-phosphorylation was 
found in the NW group on day 2 compared with day 1 (P = 0.0740). When groups 
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Figure 5.1: RT-volume on acute days1 (left side) and 2 
(right side) for NW and Milk groups. Y-axis shows 
training volume in kg (repetitions x series x intensity). * 
indicates significant change (P<0.0001) from acute day 1 
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were pooled by gender, comparison of acute day 1 and 2 showed no differences 
(P>0.05). 
 
5.3. 4E-BP1 
Ratio of phosphorylated 4E-BP1 (Thr 70) to total 4E-BP1 did not change significantly 
(P>0.05) from baseline (pre-biopsy) in either group on acute day 1 and 2 (figure 5.2).  
There was no significant (P>0.05) differences between groups on either of the acute 
days. No significant differences (P>0.05) was found within either group when acute 
day 1 was compared with day 2. When groups were pooled by gender, comparison of 
acute day 1 and 2 showed no differences (P>0.05). 
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Figure 5.2: The ratio of phosphorylated to total protein content of p706SK (left) and 4E-BP1 (right). Red colour indicates NW 
group and blue colour indicates Milk group. Horizontal dotted lines in both figures indicate baseline values (pre-biopsy). * 
indicates significant change (P<0.05) from baseline. Above p706SK and 4E-BP1 are examples of representative western blots 
of the respective signaling proteins 
53 
 
5.4. eEF2 
Ratio of phosphorylated eEF2 (Thr56) to total eEF2 did not change significantly 
(P>0.05) from baseline (pre-biopsy) in either group on acute days 1 and 2 (figure 5.3). 
There was no significant differences (P>0.05) between groups on either of the acute 
days. No significant differences (P>0.05) was found within either group when acute 
day 1 was compared with day 2. When groups were pooled by gender, comparison of 
acute day 1 and 2 showed no differences (P>0.05). 
 
 
 
 
 
 
 
5.5. Correlations 
When correlations were done on group level, pooled by gender, or participants 
individually, between the ratio of phosphorylated/total protein content of p706SK, 
4E-BP1, eEF2 and the outcome measures 1RM leg press, m. vastus lateralis 
thickness, lean body mass and lean mass in legs, no significant (P>0.05) correlations 
were found. There were also no correlations (P>0.05) found between the ratio of 
phosphorylated/total protein of p706SK, 4E-BP1 and eEF2 on either of the acute days 
or between acute days, on both group and individual level, or when pooled by gender.  
 
 
Figure 5.3: The ratio of phosphorylated to total protein content of eEF2. Red colour indicates NW group and blue 
colour indicates Milk group. Horizontal dotted line indicates baseline values (pre-biopsy). To the left are examples 
of representative duplicate western blots of eEF2. 
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5.6. MVC acute day 1 
On acute day 1 both groups experienced a similar loss of MVC with no significant 
difference (P>0.05) between groups at both 15 minutes and 150 minutes after ended 
10RM workout (figure 5.4).  At both these time points both groups had significantly 
(P<0.05) reduced MVC compared to the baseline value. 24 hours after the workout, 
only the NW group returned to the baseline value, with the Milk group still being 
significantly reduced (P<0.05) compared to baseline. When comparing groups, there 
were no differences (P>0.05) at all-time points.  
 
 
5.7. MVC acute day 2 
On acute day 2 both groups experienced a similar loss (P>0.05) of MVC 15 minutes 
after ended 10RM workout (figure 5.4). At 150 minutes both groups still had 
significantly reduced (P<0.05) MVC compared to baseline. 24 hours after ended 
10RM workout, only the NW group returned to baseline, with the Milk group still 
being significantly reduced (P<0.05) from baseline. When comparing groups, the 
Milk group were significantly (P<0.05) reduced compared to NW 2.5 hours after 
ended 10RM workout without significant differences at any other time point. 
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Figure 5.4: Pre-workout MVC represent 100 percent (x-axis), and y-axis represent time after completed 10RM workout. 
NW and Milk groups are indicated with a red and blue line, respectively. On both acute day 1 and 2 only the NW group 
returned to baseline levels 24h after completed 10RM workout. # indicates significant (P<0.05) difference between groups. 
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5.8. Anthropometric and performance measurements 
There was no significant differences (P>0.05) between groups pre and post 
intervention (table 5.1), as was the case for all functional tests (data not shown). There 
was a tendency towards a difference (P=0.089) between groups in 1RM leg-press pre 
and post, with an increase of 41% ± 12 and 29% ± 14 for NW and Milk respectively.  
 
 
Table 5.1: Overview of long-term outcome measures after 11 weeks of strength training in NW and 
Milk groups. Pre and post intervention variables are included, along with % change from pre to post. 
Values of m. vastus lateralisis thickness in cm ±(SD) . Remaining values are in kg ±(SD) 
 
Native Whey (n = 9) 
♂ = 6 / ♀ = 3 
Milk (n = 7) 
♂ = 3 / ♀ = 4 
Variable (±SD) 
Body mass 
Lean mass 
Lean legs 
1RM Leg press  
1RM Chest press 
m. vastus lateralis 
Pre 
79.6 (19.1) 
51.2 (12.3) 
17.8 (5.6) 
174.4 (63.3) 
48.1 (20.0) 
2.2 (0.5) 
Post 
81.7 (19.0) 
52.8 (12.4) 
18.4 (5.5) 
240 (76.0) 
56.4 (21.9) 
2.4 (0.6) 
% Change 
2.8 (1.5) 
3.3 (2.5) 
4.2 (3.4) 
40.7 (12.2) 
19.1 (7.4) 
6.2 (4.7) 
Pre  
74.5 (12.8) 
47.2 (6.6) 
16.4 (13.3) 
160.4 (35.5) 
39.3 (12.0) 
1.9 (0.3) 
Post 
76.7 (12.5) 
49.7 (6.5) 
17.5 (3.2) 
204.6 (36.2) 
46.8 (10.2) 
2.1 (0.4) 
% Change 
3.1 (2.6) 
5.5 (3.2) 
7.0 (4.4) 
28.7 (13.6) 
19.1 (7.4) 
7.1 (7.0) 
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6. Discussion 
The main findings in this study were: 1) After an exhausting 10RM-workout with 
subsequent intake of either native whey or milk-protein, p70-phosphorylation was 
increased 2 hours post-exercise, whereas 4E-BP1- and eEF2-phosphorylation 
remained unchanged. 2) There were no differences in intramuscular signaling 
responses between native whey and milk protein supplementation. 3) 11 weeks of 
strength-training produced significant increases in lean body mass- and 1RM strength. 
4) Lean body mass increases, m. vastus lateralis thickness and 1RM outcome-
measures were not different between groups, nor did they show any correlations with 
acute individual intramuscular signaling responses. 
 
6.1. p70S6K 
Phosphorylation of p70 increased significantly 2 hours post-workout for Milk and 
NW groups on acute day 2, while showing a strong tendency for Milk and NW on day 
1. This is in agreement with previous studies reporting increased p70-phosphorylation 
when combining resistance exercise (RE) with subsequent protein intake (Farnfield et 
al, 2012; Karlsson et al, 2004; Moore et al, 2011; Reitelseder et al, 2011). Moore et al 
(2011) reported increased p70-phosphorylation in the trained leg 1, 3 and 5 hours 
after unilateral leg-press and knee-extension combined with intake of 25 g of whey 
protein, and phosphorylation was highly associated with a concomitant increase in 
MPS.  
 
Our participants consumed 20 g in the form of NW or Milk-protein post-exercise, 
corresponding to 0.4 g of protein/kg lean body mass (LBM). The NW and milk 
supplements had a leucine content of 2.3 g and 2.0 g, respectively. Reitelseder et al 
(2011) reported an increase in p70-phosphorylation in concert with MPS-increases 
over 1-6 hours when consuming 0.3 g/kg LBM of protein, averaging as either 17.5 g 
of whey (2 g leucine) or casein (1.5 g leucine) post-exercise, with no differences 
between whey and casein. As no differences were seen between a fast (whey) and 
slow (casein) protein source (Reitelseder et al, 2011) with less protein and leucine 
content than the NW (fast) and Milk (slow)-supplements used in this study, it could 
suggest that both our supplements contained sufficient amounts of leucine for 
inducing maximal p70-responses after RE and protein intake.  
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In contrast to our findings, some studies report no significant changes in p70-
phosphorylation after RE in elderly (Fry et al, 2011; Kumar et al, 2009. Both these 
studies (Fry et al, 2011; Kumar et al, 2009) were without post-exercise protein intake, 
in contrary to our study. As we report significantly increased p70-phosphorylation in 
elderly after RE in combination with protein intake, their lack of protein intake could 
explain their reported blunted p70-response in elderly (Kumar et al, 2009; Fry et al, 
2011). 
 
We report no difference in p70-phosphorylation between groups on either acute day, 
mirrored by a similar training volume between groups. As both exercise-volume 
(Terziz et al, 2010) and –intensity (Kumar et al, 2009) is shown to affect signaling 
responses, an unequal training-volume between groups could confound the results. 
Kumar et al (2009) reported in both young and old, a plateau in MPS-response and 
p70-phosphorylation when load is in the range of 60-90% of 1RM. Pre and post 1RM 
results confirm that all of our participants were within this 60-90% range of 1RM on 
both acute days. Furthermore, MVC-tests performed 15 minutes post-exercise shows 
an equal drop in MVC for both groups, indicating a similar degree of fatigue. This 
fatigue was present as <20% reductions in 1RM after heavy RE indicate considerable 
fatigue, without muscle damage (Paulsen et al, 2012). Training volume, intensity and 
MVC-data on both acute days all indicate similar degrees of fatigue post-exercise, 
thus both groups presumably had equal premises of induced p70-response.  
 
Groups were slightly skewed by gender, with one third and two thirds being female in 
the NW and Milk group respectively. One study in elderly (Smith et al, 2008) 
reported that only men increased their MPS in the postprandial state, while p70-
phosphorylation was similar between genders in both the post absorptive and 
postprandial state. Other studies reports similar increases in p70-phosphorylation 
between genders 2 hours after RE (Dreyer et al, 2010) and 1 and 4 hours after protein 
infusion (Smith et al, 2009). In line with the previous studies (Dreyer et al, 2010; 
Smith et al; 2008; Smith et al, 2009) when pooled by gender, we found no differences 
in p70-phosphorylation. Thus, it is unlikely that gender-differences between groups 
have affected the findings in this study. 
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Training status is reported to predict the degree of p70-phosphorylation (Farnfield et 
al, 2012). In the untrained state, elderly (mean age 68) significantly increased p70-
phosphorylation 2 hours after RE and 27 g of whey protein intake, a response not 
reproduced in the trained state (Farnfield et al, 2012). All our participants were in an 
untrained state and unfamiliar with RE on acute day 1. After 11 weeks of RE our 
participants completed acute day 2 in a more trained state, as both groups had a 
significant (P<0.05) ~65% increase in training volume concomitant with significant 
pre- to post-intervention strength-gains. Similar to our study, Farnfield et al (2012) 
participants went through 12 weeks of resistance training, but in contrast to their 
findings we do not report a blunted response in the trained state, as p70-
phosphorylation were significantly (P<0.05) increased on acute day 2.  
 
Furthermore, we do not report significant differences between groups on either acute 
day. Within each group, comparing acute day 1 with acute day 2, the NW group had a 
tendency (P= 0.0740) of a greater p70-phosphorylation on acute day 2. If our 
participants were in a state of anabolic resistance pre-intervention, we expected 
anabolic signaling to be greater in the trained state. As both groups only showed 
significant increases in p70-phosphorylation on acute day 2, and the NW group 
showing a tendency of greater phosphorylation on acute day 2 compared to acute day 
1, this is in agreement with our expectations of RE and protein intake as efficient 
countermeasures of anabolic resistance. A few differences in their (Farnfield et al, 
2012) study-design compared to ours stand out. Their exercise protocol was not a full-
body program, but single-legged knee-extension. The young participants in this study 
(Farnfield et al, 2012) significantly increased p70-phosphorylation in the trained state 
as well as the untrained state. As training volume affects p70-signalling (Terziz et al, 
2010), elderly in the more trained state might need a greater exercise-volume than 
performed in Farnfield et al (2012). Our exercise protocol was of much greater 
volume than theirs (Farnfield et al, 2012), which probably is the reason for our 
divergent reports of p70-phosphorylation in the trained state. 
 
In our study and Farnfield et al (2012) post-exercise biopsies were collected after 2 
hours. Our baseline biopsy was obtained in the postprandial state, whereas theirs were 
obtained in the post absorptive state. Protein intake alone is shown to increase p70-
phosphorylation (Dickinson et al, 2011; Fujita et al, 2007a) with leucine-content 
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proven to be of particular importance (Churchward-Venne et al, 2012). As Farnfield 
et al (2012) baseline p70-measurement in the post absorptive state presumably would 
be lower compared to ours in the postprandial state, participants being of similar age 
(~68 years old) and the fact that their supplement both had a higher protein- (27 g vs 
~20 g) and leucine-content (3.7 g vs ~2 g), there is no obvious reason to why 
Farnfield et al (2012) in contrast to our findings, reported a blunted p70-response in 
the trained state.  
 
We report no significant (P>0.05) differences between groups in p70-
phosphorylation, m. vastus lateralis thickness, LBM increases and any other 
anthropometric measurement. Correlations were subsequently both pooled by gender 
and on an individual level, but no correlations between any outcome measure and the 
magnitude of p70-phosphorylation were found, in contrast to previous reports (Baar 
& Esser, 1999; Terziz et al, 2008). Phosphorylation of p70 post-exercise has been 
reported to be highly correlated to the degree of subsequent hypertrophy in rats (Baar 
& Esser, 1999). In young men, hypertrophy, increases in whole-body fat free mass 
(FFM), leg fat free mass (LFFM), 1RM squat and mean muscle CSA after 14 weeks 
of resistance training were highly correlated with p70-phosphorylation after an pre-
intervention exercise bout (Terziz et al, 2008). In line with our study, Terziz et al 
(2008) had their participants consuming a standardized breakfast before RE and 
biopsies were collected from m. vastus lateralis. However, there are several methodic 
differences between our study and Terziz et al (2008) that could explain why we do 
not find similar correlations. Terziz et al (2008) measured p70-phosphorylation 30 
minutes post RE, whereas we had a 2 hour post RE measurement. Phosphorylation 
states are transient and highly dynamic, making the time-points of biopsy collections 
a determining factor of measured phosphorylation (Drummond et al, 2008). 
Furthermore, our study was in an older population whereas Terziz et al (2008) had 
younger participants (~21 years). As previously shown (Fry et al, 2011; Kumar et al, 
2009), this age difference could lead to differences in the magnitude of p70-
phosphorylation. Terziz et al (2008) exercise protocol was completed in 12 minutes 
consisting of 6 RM leg-press with 6 sets, a lower training volume than our 
participants, with different RE volume shown to induce varying p70-phosphorylation 
(Kumar et al, 2009). Taken together, the methodological differences and different 
outcomes in our study and Terziz et al (2008) highlight the need for future studies 
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linking acute phosphorylation states of anabolic signaling proteins with longitudinal 
outcome measures.  
 
In summary, exercise-volume and -intensity, MVC-data and gender is seemingly not 
confounding variables of our reported p70-phosphorylation between groups. Both 
NW- and Milk-groups significantly increased p70-phosphorylation 2 hours post-RE 
and protein intake on acute day 2, only showing a strong tendency on acute day 1. 
This suggest that our participants could have been in a greater state of anabolic 
resistance pre- than post-intervention. Furthermore, phosphorylation-state of p70 2 
hours post RE and protein intake is not predictive of subsequent LBM and strength 
gains in elderly men and women after 11 weeks of resistance training. We 
acknowledge that our results are based on biopsies collected 2 hours post RE, and that 
biopsies collected at other time-points could produce different results. 
 
6.2. 4E-BP1 
In line with previous studies (Hulmi et al, 2009; Dreyer et al, 2006; Fry et al, 2011) 
we report non-significant increases in 4E-BP1-phosphorylation 2 hours after RE and 
protein intake. As our participants consumed ~20 g of either NW or Milk-protein our 
findings is coherent with Hulmi et al (2009) comparing 15 g of whey protein to non-
caloric placebo-intake pre- and post-workout (total of 30 g whey), reporting non-
significant increases in 4E-BP1-phosphorylation 1 hour post-workout with whey, but 
a significant decline with placebo. The above-mentioned studies, and all studies 
subsequently discussed measure 4E-BP1-phosphorylation at Thr 37/46, in contrast to 
our data, reflecting 4E-BP1 phosphorylated at Thr70. As reported by Gingras et al 
(1999), phosphorylation at Thr 37/46 do not disrupt the binding to eIF4E, but serve as 
a prerequisite for subsequent phosphorylation at Thr70 before 4E-BP1 disrupt from 
eIF4E, allowing cap-dependent translation. Whether the methodic differences in 
choice of phosphorylation sites between our study and studies in comparison, would 
lead to greatly divergent results is of uncertainty. Gingras et al (1999) propose that 
phosphorylation of Thr37/46 is necessary as a priming event for subsequent 
phosphorylation of Thr70, thus these methodic differences probably still allow for 
comparison between studies. 
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Without post-exercise protein intake, others report a significant reduction in 4E-BP1-
phosphorylation immediately after (Deldique et al, 2008; Dreyer et al, 2008) and 1 
hour post-exercise (Drummond et al, 2008), returning to baseline 2 hours post-
exercise (Dreyer et al, 2006). These studies (Deldique et al, 2008; Drummond et al, 
2008; Dreyer et al, 2006) report in agreement with our findings an increase in p70-
phosphorylation concomitant with reduced/unchanged 4E-BP1-phosphorylation. In 
the post absorptive state, Dreyer et al (2008) reported in line with one of their 
previous studies (Dreyer et al, 2006) a significant immediate reduction in 4E-BP1-
phosphorylation, returning to baseline 1 hour post-exercise. When ingesting ~20 g of 
EEA with ~7 g leucine 1 hour post-exercise, 4E-BP1 was significantly increased 1 
and 2 hours after protein intake (Dreyer et al, 2008; Fujita et al, 2007b). In agreement 
with our findings, these studies (Dreyer et al, 2008; Fujita et al, 2007b) reported 
significant increases in p70-phosphorylation 2 hours post-exercise, but in contrast we 
do not report concomitant significant increases in 4E-BP1-phosphorylation. 
 
The reported increase in p70-phosphorylation concomitant with a decline in 4E-BP1-
phosphorylation in the early recovery phase (Deldicque et al, 2008; Drummond et al, 
2008; Dreyer et al, 2006; Dreyer et al, 2008) seem to mirror our p70-phosphorylation 
pattern. Thus, the reported early 4E-BP1-decline reported by others might have 
preceded our 4E-BP1-measurement 2 hours post-exercise. Dreyer et al (2006) 
speculate that the immediate RE-induced reduction in 4E-BP1-phosphorylation is 
associated with increased AMPK-activity, inhibiting ATP-consuming anabolic 
processes such as MPS and anabolic signaling responses. Furthermore, Dreyer et al 
(2006) challenge the generally accepted role of mTOR directly controlling subsequent 
4E-BP1-phosphorylation by reporting a disconnect between the degree of 
phosphorylated mTOR and 4E-BP1. It has been shown that p70-phosphorylation is 
rapamycin-sensitive, but 4E-BP1-phosphorylation is rapamycin-insensitive (Wang et 
al, 2005). Hulmi et al (2009) reported in agreement with our findings, significantly 
increased p70-phosphorylation concomitant with unchanged 4E-BP1-
phosphorylation. The reason to why our increased p70-response is not matched by an 
increase in 4E-BP1-phosphorylation, might be that mTOR regulate p70- and 4E-BP1-
phosphorylation via different downstream-effectors (Wang et al, 2005). However, we 
measured p70 and 4E-BP1 at the same time-point, and the lack of concomitant 
phosphorylation of both signaling proteins, may be a result of these signaling proteins 
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having a different time-course of increased phosphorylation after RE and protein 
intake  
 
As previously described, equal training-volume on acute days 1 and 2 together with 
our MVC-data 15 minutes post-workout infer similar RE-induced stimuli between our 
groups to phosphorylate 4E-BP1. 4E-BP1-phosphorylation is reported by others to be 
similar between elderly men and women in basal 4E-BP1-phosphorylation, 2 hours 
post-exercise, and after protein infusion of 0.1 g protein/kg fat free mass (FFM) per 
hour for 7 hours (Dreyer et al, 2010; Smith et al, 2009). A previous study (Smith et al, 
2008) showed that only elderly men increased 4E-BP1-phosphorylation and MPS in 
the postprandial state. When we pooled our groups by gender we found no differences 
in 4E-BP1-phosphorylation on acute day 1 (untrained state) and acute day 2 (more 
trained state). This is in agreement with the above studies (Dreyer et al, 2010; Smith 
et al, 2009). As we show similar RE-induced stimuli between groups and that gender 
does not relate to 4E-BP1-response, group differences in 4E-BP1-phosphorylation 
should reflect differences in supplements given.  
 
Similar to our findings, Dickinson et al (2014) reported unchanged 4E-BP1-
phosphorylation 2 hours post-exercise in elderly when participants ingested 10 g of 
EEA with 1.85 g of leucine. The potent effect of leucine content was elucidated when 
Dickinson et al (2014) supplemented 10 g of EEA with 3.5 g leucine, significantly 
increasing 4E-BP1-phosphorylation 2 hours post-exercise. As we found no difference 
between acute day 1 (untrained) and 2 (trained) within each group or when pooled by 
gender, we report training status not to affect 4E-BP1-phosphorylation 2 hours post 
RE and protein intake. Farnfield et al (2012) examined 4E-BP1-phosphorylation in 
elderly compared to young 2 hours post-exercise combined with a protein intake of  
26.6 g of whey protein (leucine content, 3.6 g). Elderly significantly increased 4E-
BP1-phosphorylation in both the untrained and trained state (after 12 weeks of RE), 
while their younger counterparts had unchanged 4E-BP1-phosphorylation (Farnfield 
et al, 2012). In agreement with our findings, neither elderly nor young showed 
different 4E-BP1-phosphorylation comparing pre- and post-intervention 
measurements.  
 
63 
 
We found no difference (P>0.05) in 4E-BP1-phosphorylation between groups on 
acute day 1 or 2. Our supplementation with NW and Milk containing 2.3 g and 2.0 g 
leucine respectively might be inadequate to give a potent 4E-BP1-response in elderly, 
as 3.4-7 g of leucine has been proven sufficient to significantly increase 4E-BP1-
phosphorylation, with training status not affecting the degree of phosphorylation 
(Dreyer et al, 2008; Dickinson et al, 2014; Drummond et al, 2008; Fujita et al, 2007b; 
Farnfield et al, 2012). Similar to our findings, supplementing with a leucine-content in 
the range of 1.5-2.3 seem to be insufficient to potently increase 4E-BP1-
phosphorylation (Dickinson et al, 2014; Reitelseder et al, 2011).  
 
Hulmi et al (2009) supplemented a total of 3.4 g leucine, but did not find increased 
4E-BP1-phosphorylation, in contrast to the previously mentioned studies (Dreyer et 
al, 2008; Dickinson et al, 2014; Drummond et al, 2008; Fujita et al, 2007b; Farnfield 
et al, 2012). The reason for this discrepancy could be explained by the early post RE-
measurement (1 hour) and a spread feeding pattern (Hulmi et al, 2009), shown to give 
inferior 4E-BP1-phosphorylation (Mitchell et al, 2015). As both our study and Hulmi 
et al (2009) measured 4E-BP1-phosphorylation to remain at baseline values 2 hour 
post RE, this might be a consequence of counterbalancing the previously mentioned 
4E-BP1 decline in the early recovery phase (Deldicque et al, 2008; Drummond et al, 
2008; Dreyer et al, 2006; Dreyer et al, 2008). As Hulmi et al (2009) report a strong 
tendency of 4E-BP1-phosphorylation to decrease in their placebo group, it seems that 
protein supplementation in both ours and their study is sufficient to counterbalance 
the RE-induced 4E-BP1 decline. Furthermore, it seems that protein intake is the main 
determinator of 4E-BP1-phosphorylation status as Moore et al (2011) showed equal 
4E-BP1-phosphorylation in the rested vs exercised leg 1, 3 and 5 hours post unilateral 
knee-extension combined with protein intake. 
 
If we had additional biopsies withdrawn at later time points we might have seen 
increases in 4E-BP1-phosphorylation, as anabolic signaling is shown to be delayed 
with aging (Drummond et al, 2008). In line with our findings, Drummond et al (2008) 
reported unchanged 4E-BP1-phosphorylation in the early recovery phase (0-2 hours 
after RE and protein intake, but it was significantly increased 3 hours post-exercise in 
elderly. Drummond et al (2008) supplemented with 20 g of EEA, highly enriched 
with leucine (7 g of leucine) 1 hour post exercise, while our study supplemented 
64 
 
protein immediately post exercise, thus making their 3 hour post-workout 4E-BP1-
measurement comparable with our measurement 2 hours post RE and protein-intake. 
Furthermore, Drummond et al (2008) reported 4E-BP1-phosphorylation returning to 
baseline values after 6 hours. Considering the different time-points of 4E-BP1 
measurements in light of the aforementioned studies, our 2 hour post RE and protein 
intake seem to reflect a 4E-BP1-phosphorylation state counterbalancing the RE-
induced immediate decline, and before subsequent peak phosphorylation and decline 
to baseline values at later time points (3-6 hours) (Drummond et al, 2008).  
 
Feeding pattern and source of protein is reported to affect both anabolic signaling 
responses and MPS (West et al, 2011; Mitchell et al, 2015; Reitelseder et al, 2011). 
We supplemented NW and Milk-protein as a bolus dose of 20 g immediately post-
exercise, proven to give a superior 4E-BP1-response compared to spread feeding 
(Mitchell et al, 2015). In contrast, West et al (2011) report no difference between 
bolus and spread feeding on 4E-BP1-phosphorylation. However, West et al (2011) 
report increased MPS-response to bolus feeding, while Mitchell et al (2015) report 
unchanged MPS-response in association with feeding patterns. Based on these studies 
(Mitchell et al, 2015; West et al, 2011) the choice of giving our participants post-
exercise protein intake as a single bolus should not induce a reduced response in 4E-
BP1- and p70-phosphorylation compared to a spread feeding pattern. 
 
Reitelseder et al (2011) (for further details, see p70-section) compared post-exercise 
whey vs casein intake, and reported that 4E-BP1 was phosphorylated in favour 
(P<0.05) of casein at 1, 3.5 and 6 hours after protein intake. Regardless of different 
4E-BP1-responses between whey and casein, MPS remained equal for both 
supplements 1-6 hours (Reitelseder et al, 2011). Furthermore, neither whey nor casein 
was able to significantly increase 4E-BP1-phosphorylation at any time point over 1-6 
hours, with whey showing a tendency of decreased 4E-BP1-phosphorylation 
(Reitelseder et al, 2011).  
 
Thus, based on our data and studies in comparison (Reitelseder et al, 2011; Mitchell 
et al, 2015; West et al, 2011) it appears to be a disconnect between single point-in-
time changes in signaling molecule phosphorylation, the dynamic changes in MPS, 
subsequent hypertrophy and strength gains. This disconnect is also reported by 
65 
 
Atherton et al (2010) after isolated bolus feeding of 48 g whey protein (saturating 
protein-dose, according to previously described ”muscle-full” concept) with 4E-BP1- 
and p70-phosphorylation (baseline after 2.5 hours) outlasting the associated MPS-
response (baseline after 1.5 hours).  
 
The apparent RE-induced immediate reduction (Deldique et al, 2008) in 4E-BP1-
phosphorylation is restored by protein intake (Hulmi et al, 2009; Dreyer et al, 2008; 
Farnfield et al, 2012) and in the recovery period (1-6 hours) (Dreyer et al, 2006; 
Drummond et al, 2008; Fry et al, 2011). We found no correlations between the degree 
of individual 4E-BP1-phosphorylation and any of the other outcome measures, also 
when pooled by gender. Isolated, the effect of RE seems to dephosphorylate 4E-BP1 
(Hulmi et al, 2009; Dreyer et al, 2006; Deldicque et al, 2008) and according to our 
data and others (Hulmi et al, 2009; Farnfield et al, 2012; Mitchell et al, 2015; 
Atherton et al, 2010) subsequent protein intake phosphorylates and restores this RE-
induced dephosphorylation, with no strong association to the concomitant MPS-
response (Reitelseder et al, 2011; West et al, 2011; Mitchell et al, 2015).  
 
As our participants experienced significant increases in lean body mass and strength 
gains, we have to conclude in agreement with Hulmi et al (2009) that unchanged 
acute 4E-BP1-phosphorylation (not dephosphorylated) seems sufficient for the 
eIF4E/G/A complex to form and contribute to translation initiation, allowing 
accumulating hypertrophy and strength gains after 11 weeks of RE. In line with this 
conclusion Farnfield et al (2012) reported increased 4E-BP1-phosphorylation in 
elderly while being unchanged in young participants in both the untrained and trained 
state, but with both age-groups having similar increases in 1RM strength after 12 
weeks of RE. We conclude that when measured 2 hours post RE and protein intake, 
the degree of 4E-BP1-phosphorylation is not predictive or associated with the 
magnitude of individual hypertrophy or strength gains in elderly after 11 weeks of 
RE. 
 
6.3. eEF2 
We report eEF2-phosphorylation to remain unchanged 2 hours post-exercise and 
protein intake, with no differences between groups on either of the acute days. This is 
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in agreement with Moore et al (2011) who reported eEF2-phosphorylation to be 
unchanged in both the rested and exercised leg 1, 3 and 5 hours after bilateral knee-
extension combined with 25 g of whey intake. Furthermore, Hulmi et al (2009), 
reported unchanged eEF2-phosphorylation 1 hour post exercise in combination with 
ingestion of 30 g of whey protein. Fujita et al, (2007b) reported eEF2-phosphorylation 
to be significantly reduced (activated) after ingestion of 20 g EEA with a higher 
leucine content (7 g) than our supplements at rest, and after RE combined with the 
same amount of EEA and leucine (Dreyer et al, 2008; Drummond et al, 2008). 
Whereas two of these studies were conducted in young participants (Dreyer et al, 
2008; Fujita et al, 2007b), Drummond et al (2008) shows a delayed response in 
intracellular signaling in elderly after RE and protein intake. We report unchanged 
eEF2-phosphorylation 2 hours post RE and protein intake, with Drummond et al 
(2008) reporting unchanged eEF2-phosphorylation 1 hour post RE, but a significant 
reduction in eEF2-phosphorylation after 3 and 6 hours. Thus, if we had measured 
eEF2-phosphorylation at a later time-point we might have seen a significant 
reduction. On that note, Drummond et al (2008) had their participants ingesting 20 g 
of EEA (7 g leucine) 1 hour post RE making their 3 hour post RE-measurement (2 
hour post protein intake) comparable with our 2 hour post RE and protein intake-
measurement. 
 
The leucine-content used in studies with similar doses of whey (Hulmi et al, 2009; 
Moore et al, 2011) as our NW- and Milk-supplements were far below the highly 
enriched leucine-content (7 g) used in other studies (Dreyer et al, 2008; Drummond et 
al, 2008; Fujita et al, 2007b) and may explain the discrepancy in our findings. 
Furthermore, Fujita et al (2007b) reported unchanged eEF2-phosphorylation in their 
control group not consuming nutrients, suggesting leucine-content in our supplements 
to be insufficient and comparable to not ingesting nutrients. Our reported increase in 
p70-phosphorylation was unexpectedly not mirrored by reduced eEF2-
phosphorylation, as phosphorylated p70 activates eEF2 through phosphorylation of 
eEF2 kinase (Wang et al, 2001). Fujita et al (2007b) point to their robust increase in 
p70-phosphorylation as a probable explanation for their reported decrease in eEF2-
phosphorylation. Thus, our findings are in contrast to several studies showing reduced 
eEF2-phosphorylation concomitant with increasing p70-phosphorylation (Fujita et al, 
2007b; Dreyer et al, 2008; Dreyer et al, 2010; Drummond et al, 2008).  
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In addition to no group differences in eEF2-phosphorylation we found no differences 
within groups in eEF2-phosphorylation when comparing acute day 1 and 2. Similar to 
our measurements of 4E-BP1-phosphorylation, we find no association between eEF2-
phosphorylation and training status. In elderly as previously elucidated, training status 
has been shown to have a blunting effect on p70-phosphorylation and no effect on 4E-
BP1-phosphorylation (Farnfield et al, 2012). However, Farnfield et al (2012) did not 
include eEF2 in their study for further comparisons. 
 
Our groups were as previously described, slightly skewed by gender. As we found no 
group differences, and training status to be unrelated to eEF2-phosphorylation, we 
pooled participants by gender to examine whether this skewness could confound 
group measurements. In elderly men and women, it is shown a similar decrease in 
eEF2-phosphorylation 2 hours post-exercise, and after isolated protein intake (Dreyer 
et al, 2010; Smith et al, 2009). In agreement with these studies (Dreyer et al, 2010; 
Smith et al, 2009) we found no differences in eEF2-phosphorylation between genders, 
but in contrast we found eEF2-phosphorylation to remain unchanged after RE and 
protein intake. 
 
We show equal RE-induced stimuli between groups and that gender or training status 
does not relate to eEF2-response, thus potential group differences in eEF2-
phosphorylation should reflect differences in our given supplements. As we found no 
group differences, we report no supplemental effect on eEF2-phosphorylation, and 
previously mentioned studies (Dreyer et al, 2008; Drummond et al, 2008; Fujita et al, 
2007b) suggest leucine content in both our supplements might be insufficient to 
robustly decrease eEF2-phosphorylation. It should be noted that in these studies 
(Dreyer et al, 2008; Drummond et al, 2008; Fujita et al, 2007b) baseline biopsies were 
collected in the post absorptive state, thus subsequent biopsies collected post RE and 
protein intake would presumably reveal greater changes in phosphorylation-state 
compared to our biopsies collected in the fed state. These methodic differences has 
been shown to affect eEF2-phosphorylation after RE and protein intake (Deldicque et 
al, 2010). Deldicque et al (2010) had their participants either fasting or fed a 
carbohydrate-rich breakfast pre-exercise, with post-exercise biopsies collected 1 and 4 
hour after the workout ended, and greater reductions in phosphorylated eEF2 was 
seen in the group not consuming breakfast pre-exercise (Deldicque et al, 2010).  
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Our contradicting findings of increased p70-phosphorylation not being mirrored by 
reduced eEF2-phosphorylation are in line with studies questioning the importance of 
acute eEF2-phosphorylation. The phosphorylation pattern of eEF2 in response to 
isolated RE and protein intake, and the two stimuli combined seem to be 
contradicting. When consuming a large bolus of 48 g of whey, eEF2-phosphorylation 
remained unchanged for 6 hours (Atherton et al, 2010), in contrast to reduced eEF2-
phosphorylation in other studies with 20 g of EEA highly enriched leucine content 
(Dreyer et al; 2006; Drummond et al, 2008; Fujita et al, 2007b).   
 
West et al (2011) compared bolus vs spread feeding pattern, with spread feeding 
inducing a significantly greater reduction in eEF2-phosphorylation compared to bolus 
feeding. However, the greater reduction in eEF2-phosphorylation after spread feeding 
was concomitant with reduced MPS compared to bolus feeding 1, 3 and 5 hours post 
protein intake (West et al, 2011). In another study there were no differences between 
bolus and spread feeding in regards to MPS, with eEF2 remaining unchanged from 
baseline with both feeding patterns (Mitchell et al, 2015). Kumar et al (2009) reported 
in both young and old that eEF2 was  20% less phosphorylated immediately after RE 
before rebounding to 120%  of baseline values 1 hour after (authors stated this as a 
highly inactivated state), in great contrast to similar studies (Dreyer et al, 2006; Fujita 
et al, 2007b). Furthermore, Moore et al (2011) reported a reduction in eEF2-
phosphorylation in the exercise and fed condition compared to rested and condition, 
but unexpectedly unchanged compared to rested and fasted condition. In line with 
these contradicting findings, Kumar et al (2009) stated acute eEF2-phosphorylation to 
be of little biological relevance and agrees with our reports of eEF2-phosphorylation 
2 hours post RE and protein intake not being individually correlated to any outcome 
measure after 11 weeks of resistance training in elderly men and women. 
 
6.4. Hypertrophy and strength  
The most obvious finding from our study was the great improvements in the physical 
state of our participants, emphasizing the potent effect of progressive resistance 
training combined with protein supplementation. As elucidated in a comprehensive 
meta-analysis (Cermak et al, 2012), it is likely that our protein supplementation, 
ensuring a daily intake of  >1.2 g/kg/body mass during the 11 weeks of resistance 
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exercise was a contributor to our participants’ increases in 1RM strength and 
hypertrophy. Our participants experienced a large increase in 1RM strength and lean 
body mass (LBM) compared with meta-analysis in both young and old (Cermak et al, 
2012) and old >65 years (Peterson et al, 2010, Peterson et al, 2011). Similar to our 
study, mean number of exercises performed was ~8, with ~10 repetitions in each 
exercise, and training frequency was ~3 times per week (Cermak et al, 2012; Peterson 
et al, 2011; Peterson et al, 2010). Mean duration of the training interventions was 
~17-20 weeks (Peterson et al, 2010&2011) and ~12 weeks (Cermak et al, 2012). 
When examining studies in older populations of both genders (Peterson et al, 2011), 
mean gains in whole body fat free mass was ~1.1 kg after 20 weeks of training, with 
our participants showing a mean increase of ~2 kg in 11 weeks. Increases in 1RM leg 
press and chest press from baseline after ~17 weeks of resistance training have been 
reported to be ~32 kg and ~10 kg respectively (Peterson et al, 2010), with our 
participants showing a mean increase in leg press and chest press of ~55 kg and ~8 kg 
respectively, in only 11 weeks. Thus, our full-body progressive resistance training 
program combined with protein supplementation seems to be efficient 
countermeasures to the reported age-related atrophy and anabolic resistance (Janssen 
& Ross, 2005; Cuthbertson et al, 2005, Katsanos et al, 2005&2006; Kumar et al, 
2009; Paddon-Jones et al, 2004; Yang et al, 2012a&b). 
 
6.5. Recovery 
When examining MVC data, the Milk group had a significantly reduced (P<0.05) 
MVC 2.5 hours after RE and protein intake on acute day 2 compared to the NW 
group. The reduction in MVC was, however, not associated with the magnitude of 
phosphorylation of p70, 4E-BP1 and eEF2. As we report similar training volume and 
MVC 15 minutes post RE and protein intake, group differences 2.5 hours after 
exercise could reflect differences in recovery from metabolic fatigue and partial 
recovery of structural damages (Paulsen et al, 2012). Etheridge et al (2008) showed 
that immediate post RE protein intake resulted in MVC returning faster to baseline 
(24h) after an exhausting downhill-run, inducing delayed onset muscle soreness 
(DOMS), while the placebo-group were significantly reduced compared to baseline 
(Etheridge et al, 2008). Since NW is more readily absorbed and digested than milk, 
group differences in recovery 2.5 hours after exercise might be contributing to a more 
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rapid and enhanced recovery with NW. Furthermore, on both acute days, only the 
NW group returned to baseline-values 24 h after RE and protein intake, although 
differences between groups at 24 h failed to reach significance. Since our participants 
only exercised 3 times per week, >48 h recovery between exercise-bouts might be 
sufficient for equal recovery between groups. These findings make it interesting to 
examine whether our studied supplements would reveal different longitudinal 
outcome measures when given to participants adhering to a more frequent exercise-
regime. If resistance exercise was performed on a daily basis, rapid recovery would be 
of greater importance, not reflected in our participants with >48 h recovery between 
exercise bouts.  
 
6.6. Linking acute phosphorylation to long-term hypertrophy 
and strength gains 
None of our studied signaling proteins were phosphorylated differently between or 
within groups, and groups were similar in all long-term outcome measures. We 
expected intracellular signaling to be enhanced on acute day 2, due to chronic RE and 
protein supplementation overcoming the assumed anabolic resistance in the untrained 
state. The only indication of enhanced signaling in the trained state was p70-
phosphorylation being significantly increased on acute day 2 in both groups, while 
only showing a strong tendency of increased phosphorylation in both groups on acute 
day 1. However, only the NW group showed a tendency of greater p70-
phosphorylation on acute day 2, compared to acute day 1.  
 
The difference in leucine content between the NW (2.3 g) and milk supplements (2.0 
g) might have been too small to detect differences in the current study design. 
However it is surprising we did not find supplemental differences as the faster NW 
absorption-rate has been reported to significantly increase [blood leucine] 0-5 hours 
post RE and protein intake (Aas, S, 2014). We acknowledge that we do not have 
blood data to confirm whether NW and milk induced different [blood leucine] in our 
study. Furthermore, unchanged phosphorylation of 4E-BP1 and eEF2 might have 
been due to both supplements not being sufficiently above the leucine trigger at >2 g, 
as several studies with >3.5 g leucine show increased and decreased phosphorylation 
of 4E-BP1 and eEF2, respectively. Yang et al (2012b) reported a saturated MPS-
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response with 20 g of whey at rest in elderly, and an incremental response from 20-40 
g of whey after RE. We gave our participants equal doses of native whey/milk both at 
rest and after RE, thus doubling our given doses after RE might have revealed 
supplemental differences we could not detect in our current study-design. We saw a 
tendency of increased 1RM leg-press in the NW group compared to the Milk-group. 
In light of this, future studies should examine whether increasing our given doses 
after RE could reveal supplemental differences between native whey and milk.  
 
As individual signaling responses were highly varied between participants, the group 
mean itself do not identify potential responders/non-responders. Thus, in addition to 
examining correlations on a group level, this was also done in participants 
individually and pooled by gender. When examined individually there was no pattern 
to be seen in terms of a high/low-responder in e.g. p70-phosphorylation 
simultaneously being a high/low-responder in 4E-BP1- and eEF2-phosphorylation. 
Furthermore, we wanted to examine whether our participants’ physiological outcome-
measures were mirrored by phosphorylation-states of key anabolic signaling proteins 
after an acute exercise bout. We conclude that outcome-measures were not related to 
the individual phosphorylation-states of p70, 4E-BP1 and eEF2, 2 hours after an 
initial exposure to an exhausting 10RM-bout combined with protein intake of either 
native whey or milk. As there were no group differences in phosphorylation and 
outcome-measures, our reported phosphorylation pattern, with an increase in p70-
phosphorylation together with unchanged 4E-BP1- and eEF2-phosphorylation 2 hours 
after RE and protein intake seem to be permissive for subsequent hypertrophy and 
strength gains on a group level.  
 
In contrast to our study, Mayhew et al (2009) has shown that acute p70- and 4E-BP1-
phosphorylation is related to subsequent gains in LBM after 16 weeks of RE in both 
elderly and young. Furthermore, the same study showed that although these 
phosphorylation patterns were related to lean body mass gains, they were not related 
to the acute measures of MPS (Mayhew et al, 2009). While some find acute 
phosphorylation patterns to predict subsequent hypertrophy (Baar & Esser, 1999; 
Terziz et al, 2008; Mayhew et al, 2009), our findings suggest acute phosphorylation 
patterns of important translation signaling proteins downstream from mTOR is not 
predictive of reported outcome measures after 11 weeks of resistance training and 
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protein supplementation. This statement is limited by the fact that we only measured 
these phosphorylation patterns 2 hour post RE and protein intake.  
In agreement with our findings, a large study including both young and old 
participants, showed that downstream mTOR-effectors such as p70, 4E-BP1 and 
eEF2 was not directly correlated to resistance exercise-induced changes in LBM 
(Phillips et al, 2013). Mitchell et al (2014) reported initial acute measures of MPS to 
be disconnected intracellular signaling and not predictive of hypertrophy after 16 
weeks of resistance exercise. Similar to our study, Mitchell et al (2014) found no 
correlations on an intra-individual level between participants initial response to an 
exercise bout combined with protein intake (which they were supplemented with 
throughout the study), and DXA-measures of lean body mass and MRI-measures of 
muscle volume after 16 weeks of resistance training.  
 
Several studies already described, clearly show a disconnect between 
phosphorylation-states of p70, 4E-BP1 and eEF2, concomitant MPS and hypertrophy 
(Atherton et al, 2010; Reitelseder et al, 2011; Kumar et al, 2009; Grenhaff et al, 2008; 
Mitchell et al, 2015; West et al, 2011; Mitchell et al, 2014; Farnfield et al, 2012). 
Thus, a model where MPS-increases follow from proportionate alterations in the 
phosphorylation-pattern of p70, 4E-BP1 and eEF2, leading to predictions of long-
term strength-gains and hypertrophy seems to be an oversimplification. This agrees 
with our findings as phosphorylation-patterns of  p70, 4E-BP1 and eEF2 were not 
able to explain our participants response to chronic resistance training and protein 
intake. As resistance exercise is shown to elevate MPS for at least 24 hours (Tang et 
al, 2008) and up to 48 hours (Phillips et al, 1997), pinpointing crucial time-points of 
measuring acute anabolic signaling responses, which furthermore predicts outcomes 
of long-term resistance training and protein supplementation seems difficult. 
Furthermore, one has to accept a clear limitation when analyzing muscle tissue 
collected from biopsies, that results might not be reflecting the processes on a whole 
muscle- and whole body-level.  
 
There is a need for more studies implementing a longitudinal aspect in relation to 
acute measurements to better understand how and if, different points-in-time 
phosphorylation-patterns downstream of mTOR reflect and predict subsequent 
hypertrophy and strength gains. Most studies examining intracellular signaling 
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responses, link phosphorylation patterns to acute measures of MPS and lack the 
longitudinal outcome measures we present in this study. We acknowledge the 
limitations of our measured phosphorylation-patterns only reflecting the anabolic state 
in m. vastus lateralis 2 hours post RE and protein intake. Thus it is of interest to 
further elucidate various points-in-time measurements of the anabolic signaling 
pathways related to hypertrophy and strength gains. This should be executed in 
various populations with different training backgrounds and age-groups, and after 
different training regimes. 
 
6.7. Conclusion 
We conclude that supplementation with equal amounts of protein from native whey 
and milk, in combination with strength training resulted in similar signaling for 
muscle hypertrophy and similar gains in m. vastus lateralis thickness, muscle mass 
and muscle strength in elderly. We expected post-intervention signaling-responses to 
be of greater magnitude, but there was only a tendency of greater p70-
phosphorylation on acute day 2 compared to day 1. Furthermore we show that 
strength training combined with protein supplementation significantly increases 1RM 
strength and hypertrophy in an elderly population of both genders. There were no 
group differences, which could be related to a large daily protein intake (>1.2 g per 
kg/body mass) in all participants, possibly confounding the hypothesized effect of a 
higher leucine content and faster absorption-rate in native whey. Moreover, the 
difference in leucine-content between NW and milk might have been too small to 
induce different responses between supplements in our study-design. 
 
Several studies have been using p70-, 4E-BP1- and eEF2-phosphorylation as indexes 
of anabolic response to strength training and protein intake. Our long-term outcome-
measures were not mirrored by individual signaling responses, emphasizing that acute 
measures of intracellular signaling should be interpreted with caution. To be 
considered reliable indexes of response to repeated exposures of strength training and 
protein intake, acute measures should be viewed in context with longitudinal outcome 
measures.  
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8. Tables 
Table 3.1: Overview of studies examining the effect of resistance exercise (RE) and/or protein intake 
on phosphorylation of p70, 4E-BP1 and eEF2. +* indicate significant increase. -* indicate significant 
decrease. = indicate no change. (+) or (-) indidcate a tendency of change. All biopsies were collected 
from m. vastus lateralis………………………………………………………………………………………Pg.29 
 
Table 4.1: Overview of inclusion/exclusion criteria. All participants adhered to these criteria to 
participate in this study……………………………………………………………………………………….Pg.36 
 
Table 4.2: Baseline values of the NW and Milk group. There were no significant differences between 
groups (P>0.05). Values are given as a mean ± (SD)...………………………………………………….Pg.41 
 
Table 4.3: Table showing the amino acid profile, fat and carbohydrate content in native whey and 
milk. Doses were given as an individual sachet after the 10RM workout and two times per day 
throughout the 11 weeks of training. Essential amino acids are labeled with a *……………………Pg.44 
 
Table 4.4: Table showing all 6 exercises performed on acute days. Training load was 10RM, and load 
was added for each set if sets were not exhausting..……………………………………………………...Pg.45 
 
Table 4.5: Table showing all primary and secondary antibodies used, with their respective dilutions. 
Primary antibodies were phospho- and total protein-specific. Secondary antibody used was Anti-rabbit 
IgG HRP-linked antibody….…………………………………………………………………………………Pg.49 
 
Table 5.1: Overview of long-term outcome measures after 11 weeks of strength training in NW and 
Milk groups. Pre and post intervention variables are included, along with % change from pre to post. 
Values of m. vastus lateralisis  thickness in cm ±(SD) . Remaining values are in kg 
±(SD)……………………………………………………………………………………………………………Pg.55 
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9. Figures 
Figure 3.1: Simplified overview of suggested signaling pathways regulating MPS in skeletal muscle. 
Studied signaling proteins p70S6K, 4E-BP1 and eEF2 are highlighted with a yellow line. Green boxes 
indicate positive regulators of MPS and red boxes indicate negative regulators of MPS.………....Pg.23 
 
Figure 4.1: Overview of the randomization process. Of the 26 participants completing this study, 16 
took part in the acute part of the study. NW group consisted of 9 participants (6 men and 3 women) and 
Milk group of 7 participants (3 men and 4 women)…...………………………………………………….Pg.37 
 
Figure 4.2: Overview of the preliminary testing day, starting with each participant meeting up with the 
project manager before subsequent testing procedures were completed………………………….....Pg.39 
 
Figure 4.3: An example timeline showing an acute day with a participant consuming a standardized 
breakfast at NSSS 08:00. The specific time-points for biopsies and MVC are highlighted with red and 
green arrows, respectively. 10RM training bout and subsequent protein intake are highlighted in blue 
writing………………………………………………………………………………………………………..…Pg.42 
 
Figure 4.4: An example picture of UV-activation of two gels run as duplicates. Picture shows protein 
distribution after electrophoresis. The Gene-On-marker used for later cutting of membranes is shown 
to the right………………………………………………………………………………………………………Pg.47 
 
Figure 4.5: Picture of the same duplicate gels (top) as in figure 6, and membranes (bottom) after 
blotting. Comparing figure 6 with the top two gels one can clearly see how proteins has been 
transferred to their respective membranes (bottom) for further handling and analysis.……...…..…Pg.48 
 
Figure 5.1: RT-volume on acute days1 (left side) and 2 (right side) for NW and Milk groups. Y-axis 
shows training volume in kg (repetitions x series x intensity). * indicates significant change 
(P<0.0001) from acute day …………...………………………………………………………………….….Pg.51 
 
Figure 5.2: The ratio of phosphorylated to total protein content of p706SK (left) and 4E-BP1 (right). 
Red colour indicates NW group and blue colour indicates Milk group. Horizontal dotted lines in both 
figures indicate baseline values (pre-biopsy). * indicates significant change (P<0.05) from baseline. 
Above p706SK and 4E-BP1 are examples of representative western blots of the respective signaling 
proteins…………………………………………………………………………………………………….…...Pg.52 
 
Figure 5.3: The ratio of phosphorylated to total protein content of eEF2. Red colour indicates NW 
group and blue colour indicates Milk group. Horizontal dotted line indicates baseline values (pre-
biopsy). To the left are examples of representative duplicate western blots of eEF2…….....……...Pg.53 
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Figure 5.4: Pre-workout MVC represent 100 percent (x-axis), and y-axis represent time after 
completed 10RM workout. NW and Milk groups are indicated with a red and blue line, respectively. 
On both acute day 1 and 2 only the NW group returned to baseline levels 24h after completed 10RM 
workout. # indicates significant (P<0.05) difference between group….…………………………….…Pg.54 
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10. Abbreviations 
Akt/PKB protein kinase B 
1RM  one repetition maximum 
4E-BP1 eukaryotic translation initiation factor 4E binding protein 1  
BCAA  branched chain amino acid 
BMD  bone mineral density 
BMI  body mass index 
CSA  cross sectional area 
DGK  diacylglyserol kinase 
DXA  dual X-ray absorptiometry 
EEA  essential amino acid 
eEF2  eukaryot elongation factor 2 
eIF4E  eukaryotic initiation factor of translation-4E 
GTP  guanosine triphosphate 
FFM  fat free mass 
LAT1  large neutral amino acid transporter 1 
LBM  lean body mass 
MPS  muscle protein synthesis 
MPB  muscle protein breakdown 
mTORC1/2 mammalian target of rapamycin complex 1/2 
MVC  maximal voluntary contraction 
p70S6K 70-kD S6 protein kinase 
PA  phosphatic acid 
PDK-1  3-phosphoinositide-dependant protein kinase 1 
PI3-K  phosphatidylinositol-3-kinase 
Rag GTPase ras-related guanosin-triphosphate 
RE  resistance exercise 
RFD  rate of force development 
RCT  randomized controlled trial 
Rheb  ras homolog enriched in brain 
RM  repetition maximum 
SNAT2 sodium coupled neutral amino acid transporter 2 
Thr  threonine 
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tRNA  transfer ribo nucleic acid 
TSC 1/2 tuberous sclerosis 1/2 
UPS  ubiquitin-proteasome system  
MuRF1  muscle specific RING Finger 1 
MAFbx  muscle atrophy F-box  
FOXO              Forkhead box (transcription factors FOXO1, FOXO3a, FOXO4)  
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11. Appendix 1 
 
 
 
 
Forsøkspersoner søkes! 
«Styrketrening og melkeprotein» 
 
Prosjektet ”Hvordan påvirker forskjellige melkeproteiner muskelproteinbalanse 
hos eldre?” har til hensikt å undersøke effekten av forskjellige melkeproteiner på 
muskelvekst gjennom en 12 ukers treningsperiode hos yngre og eldre.  
 
Vi søker etter kvinner og menn over 70 år som ikke trener regelmessig, men ønsker å 
komme i bedre fysisk form 
 
Studien vil foregå i perioden september-desember 2014 og innebærer en rekke tester 
før og etter treningsperioden. Det vil bli ca. 4 oppmøter på 2-3 timer i forkant og 
etterkant av treningsperioden for testing.  
 
Treningen vil foregå 3 ganger per uke i grupper på 3 med personlig trener på alle 
økter ved Norges idrettshøgskole.        
 
Før og etter treningsperioden vil det bli tatt blodprøver og muskelbiopsier 
 
Er du interessert, ta kontakt med : 
Håvard Hamarsland: 93445916; haavardh@nih.no 
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12. Appendix 2 
 
 
 
Forespørsel om deltakelse som forsøksperson 
Hvordan påvirker inntak av forskjellige melkeproteiner 
muskelproteinbalanse hos eldre? 
 
Dette skrivet er til alle potensielle forsøkspersoner. Vi ber om din deltakelse i 
prosjektet, så fremt du oppfyller kriteriene: Du må være 70 år eller eldre, være 
normalt aktiv, og ellers kunne gjennomføre styrketrening. Du kan ikke bruke 
spesifiserte medikamenter eller kosttilskudd (proteinpulver, kreatin eller lignende). 
Hvis du bruker slike kosttilskudd kan du likevel delta som forsøksperson ved at du 
slutter med tilskuddet senest én uke før prosjektstart. Du kan ikke delta om du er 
laktoseintolerant, har melkeallergi eller er allergisk mot lokalbedøvelse (tilsvarende 
det man får hos tannlegen).  
 
Bakgrunn og hensikt med forsøket 
Sarkopeni (aldersrelatert muskelsvinn) har de siste årene fått mye oppmerksomhet da 
det i tillegg til å redusere funksjon og livskvalitet i hverdagen også disponerer for 
flere livsstilssykdommer (bla. type II diabetes og osteoporose). Styrketrening og et 
økt inntak av proteiner har vist seg å kunne motvirke muskelsvinnet. Inntak av 
proteiner har i seg selv en umiddelbar muskeloppbyggende effekt ved at 
proteinsyntesen øker; og kombinerer vi proteininntak med styrketrening får vi en 
vesentlig kraftigere effekt. Økningen i proteinsyntesen bestemmes i stor grad av 
mengden og kvaliteten på proteinet, samt hvor raskt proteinet tas opp i blodet. I 
tillegg til proteinsyntesen vil også proteinnedbrytningen til enhver tid spille inn på 
proteinomsetningen i muskulaturen. Sammenliknet med proteinsyntesen vet vi lite om 
hvordan proteinnedbrytningen påvirkes av proteininntak etter styrketrening. Ny 
kunnskap om dette kan gi oss bedre forutsetninger for å maksimere utbyttet av 
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styrketrening, som vil være av stor interesse for eldre med tanke på livskvalitet og 
funksjon i hverdagen.  
 
I denne studien ønsker vi å undersøke om et nyutviklet myseprotein produsert av 
Tine® kan bedre effekten av styrketrening (føre til større økning i muskelmasse 
og styrke). Dette nye myseproteinet vil sammenliknes med effekten av vanlig 
lettmelk. 
 
Dette er et dobbelt blindet, randomisert, kontrollert studie, som betyr at verken du 
eller forskerne du kommer i kontakt med vet hvilken drikk du inntar.  
 
Gjennomføringen av forsøket 
Forsøket går kort fortalt ut på å gjennomføre en treningsperiode på 12 uker med 
styrketrening tre ganger i uken. Gjennom denne perioden inntas det to enheter på 0,6 l 
daglig med enten melk eller nativ myse. Du vil bli tilfeldig trukket (randomiseres) til 
én av gruppene. Før og etter treningsperioden vil det gjennomføres en rekke tester (se 
under) for å se på effekten av de forskjellige drikkene.  
 
Før treningsperioden 
Du skal møte på Norges idrettshøgskole 4 ganger for tilvenning til tester og 
treningsøvelser, styrketester, måling av kroppssammensetning (DXA), en legesjekk 
og muskelbiopsier i ukene før forsøket. I tillegg må du møte for en MR-analyse hos 
Curato røntgen. Tidspunkter for de ulike oppmøtene avtales individuelt. Under følger 
et eksempel på tidsplan for tester: 
Dag 1: Underskrevet samtykke og helseerklæring. Fastende blodprøve, DXA-scan, 
medbrakt frokost, tilvennig til styrketester og funksjonelle tester (ca. 2 timer). 
Minimum 2 dager hvile. 
Dag 2: Gjennomføring av styrketester og funksjonelle tester (ca 1 time). 
Minimum 2 dager hvile. 
Dag 3: MR hos Curato røntgen (ca. 30 minutter). 
Dag 4: Akuttforsøk (ca. 8timer) eller prebiopsi (ca 45 minutter). 
 
Før treningsstudien må du også gjennomføre to kostintervju, en tilsvarende 
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kostregistrering vil gjentas mot slutten av treningsperioden. I de to siste dagene før 
tester og biopsi(er) må du avstå fra all krevende fysisk aktivitet (trening).  
 
Akuttforsøk 
Ti deltakere fra hver gruppe trekkes tilfeldig ut til å gjennomføre et akuttforsøk før og 
etter treningsperioden, dette innebærer 2 biopsier før treningsperioden og 2 biopsier 
etter treningsperioden (totalt 4 biopsier). De resterende deltakerne i hver gruppe deltar 
ikke i akuttstudien og tar bare én biopsi før og én etter treningsperioden. Hensikten 
med akuttforsøket er å måle hvordan muskulaturens respons til trening forandres over 
treningsperioden og hvordan inntak av de to drikkene påvirker dette. Oppstart denne 
dagen vil være mellom kl. 0800 og 0900, og forsøket er ferdig mellom kl. 1530 og 
1630. Før vi gjennomfører treningsøkten vil vi ta en biopsi og gjennomføre en 
styrketest i et kneekstensjonsapparat. Treningsøkten vil være identisk med noen av 
øktene som gjennomføres senere i treningsperioden. Etter treningsøkten vil du innta 
en av de to drikkene, og det vil bli tatt en biopsi tre timer etter økten. Det vil også bli 
tatt blodprøver (gjennom venekateter) flere ganger i løpet av dagen, og gjennomført 
styrketester rett etter økten, 3 timer etter økten og 24 timer etter økten, for å måle 
restitusjon. Dermed vil du måtte sette av en hel dag til testdagen (fra 0700-0800 frem 
til ca. 1530-1630) og 30 min til styrketesting og blodprøve dagen etter.  
Treningsperioden 
Treningsperioden starter når man har gjennomført alle testene, og den varer i 12 uker. 
I disse 12 ukene skal det trenes styrke tre ganger i uken (mandag, onsdag og fredag) i 
grupper på tre deltakere med oppfølging av en personlig trener på alle økter. Drikkene 
inntas to ganger om dagen; etter trening og på kvelden på treningsdager, og morgen 
og kveld på treningsfrie dager.  
Etter treningsperioden gjennomføres alle testene på nytt for å måle endringer.  
 
Tester 
DXA: ved et av oppmøtene før testingen gjøres en DXA-analyse for å måle 
kroppssammensetningen som vil danne grunnlaget for de standardiserte måltidene ved 
testgjennomføringen. Denne testen innebærer at deltakerne ligger stille i ca. 10 
minutter. 
MR: for å måle muskelvekst i lår- og overarmsmuskulaturen benyttes en MR-analyse. 
Denne testen innebærer at du må ligge i ro ca. 15 minutter. 
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1RM tester: for å måle styrke vil det testes hvor mye du kan løfte maksimalt en gang i 
to øvelser som heter beinpress og brystpress.  
Muskelfunksjonstest: testingen av muskelfunksjonen gjøres i et kneekstensjonsapparat 
som er låst ved 90° i kneleddet. 
Funksjonelle tester: en test av hvor raskt du kan reise seg fra en stol fem ganger på 
rad, samt en test av hvor raskt du kan gå opp en trapp vil bli brukt til å si noe om 
funksjon i hverdagen og mobilitet.   
Blodprøver: blodprøvene vil tas i sammenheng med biopsiene og vil gjøres gjennom 
venekatetrene slik at det ikke blir noen ekstra stikk for blodprøver.  
Biopsier: For de som tilfeldig velges til å være med på akuttforsøket blir det to 
biopsier før og to biopsier etter treningsperioden. For de som ikke skal være med på 
akuttforsøket blir det én biopsi før og én etter treningsperioden.  
Biopsiene tas ut på følgende måte: 
 Huden og bindevevet lokalbedøves der vevsprøven skal taes. 
 Et snitt på ca. 1-2 cm gjøres gjennom hud og muskelfascien. 
 En nål med diameter på 6 mm føres inn (2‐3 cm) og 1‐3 små biter av 
muskulaturen tas ut (total 2-300 mg). 
 Snittet lukkes med tape (strips). 
 
Eventuelle ulemper ved å delta 
Deltakelse i prosjektet vil kreve en del tid og oppmerksomhet.   
Trening skal gjennomføres med stor belastning, og vil medføre en viss risiko for 
skade og følelse av sårhet/stølhet i muskulaturen.  
Venekateter medfører en liten infeksjonsfare og det kan oppleves ubehagelig. 
Vevsprøvetakninger (biopsier) medfører en liten infeksjonsfare, og ubehag/smerter 
kan oppleves under inngrepet. Du kan også oppleve lette til moderate smerter i 1 -2 
døgn etter inngrepet.  
Du vil få et lite arr etter snittet i huden; arret vil sakte bli mindre tydelig. Enkelte 
personer vil kunne få en fortykning av huden i arrområdet. 
 
Personvern 
Vi vil kun lagre informasjon om deg under ditt forsøkspersonnummer. Undervis i 
forsøket vil vi oppbevare en kodeliste med navn og forsøkspersonnummer. Denne 
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kodelisten vil fysisk være låst inne, slik at det er kun forskerne tilknyttet studien som 
har adgang til den. Alle som får innsyn i informasjon om deg har taushetsplikt. 
Innsamlet data vil bli anonymisert etter 15 år (kodelisten destrueres). 
  
Alle prøver vil analyseres ”blindet”, det vil si at forskerne som utfører den enkelte 
analysen ikke vet hvilken forsøksperson prøven kommer fra (verken 
forsøkspersonnummer eller gruppe). Prøver vil bli analysert ved NIH (biopsier), 
Universitet i Oslo (ernæringsinstituttet; biopsier og blod) og Universitetet i Arkansas, 
USA (biopsier og blod). Det vil ikke være mulig å identifisere deg i resultatene av 
studien når disse publiseres.  
 
Biobank 
Biopsiene og blodprøvene vil bli oppbevart i en forskningsbiobank uten kommersielle 
interesser (vurdert av Regional Etisk Komite). Hvis du sier ja til å delta i studien, gir 
du også samtykke til at det biologiske materialet og analyseresultater inngår i 
biobanken. Prøvene vil bli lagret til år 2020. Ansvarlig for biobanken er Professor 
Truls Raastad ved Seksjon for fysisk prestasjonsevne ved NIH. Det biologiske 
materialet kan bare brukes etter godkjenning fra Regional komité for medisinsk og 
helsefaglig forskningsetikk (REK). Hvis du sier ja til å delta i studien, gir du også ditt 
samtykke til at prøver og avidentifiserte opplysninger utleveres til ernæringsinstituttet 
ved universitetet i Oslo og universitetet i Arkansas.  
 
Innsynsrett og oppbevaring av materiale 
Hvis du sier ja til å delta i studien, har du rett til å få innsyn i hvilke opplysninger som 
er registrert om deg. Du har videre rett til å få korrigert eventuelle feil i de 
opplysningene vi har registrert. Dersom du trekker deg fra studien, kan du kreve å få 
slettet innsamlede prøver og opplysninger, med mindre opplysningene allerede er 
inngått i analyser eller brukt i vitenskapelige publikasjoner. 
 
Informasjon om utfallet av studien 
Etter at data er innsamlet og analysert vil vi avholde et møte for alle forsøkspersonene 
der vi presenterer resultatene fra studien. 
 
Forsikring 
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Deltakere i prosjektet er forsikret dersom det skulle oppstå skade eller kompikasjoner 
som følge av deltakelse i forskningsprosjektet. NIH er en statlig institusjon og er 
således selvassurandør. Dette innebærer at det er NIH som dekker en eventuell 
erstatning og ikke et forsikringsselskap. 
 
Finansiering 
Prosjektet er fullfinansiert av Tine® og Norges forskningsråd. 
 
Publisering 
Resultatene fra studien vil offentliggjøres i internasjonale, fagfellevurderte, tidsskrift. 
Du vil få tilsendt artiklene hvis du ønsker det. 
 
Samtykke 
Hvis du har lest informasjonsskrivet og ønsker å være med som forsøksperson i 
prosjektet, ber vi deg undertegne “Samtykke om deltakelse” og returnere dette til en 
av personene oppgitt nedenfor. Du bekrefter samtidig at du har fått kopi av og lest 
denne informasjonen. 
Det er frivillig å delta og du kan når som helst trekke deg fra prosjektet uten videre 
begrunnelse. Alle data vil, som nevnt ovenfor, bli avidentifisert før de blir lagt inn i 
en database, og senere anonymisert. 
Dersom du ønsker flere opplysninger kan du ta kontakt med Håvard Hamarsland 
på tlf: 93 445 916 eller e-post: haavardh@nih.no, Gøran Paulsen på tlf: 93429420, 
eller Truls Raastad på tlf: 23 26 23 28 el. 913 68 896 
Vennlig hilsen 
Håvard Hamarsland (Stipendiat) 
Gøran Paulsen (forsker) 
Truls Raastad (Professor) 
Samtykke til deltakelse i studien Hvordan 
påvirker inntak av forskjellige melkeproteiner 
muskelproteinbalanse hos eldre? 
 
 
Jeg er villig til å delta i studien  
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---------------------------------------------------------------------------------------------------------------- 
(Signert av prosjektdeltaker, dato) 
 
 
 
Jeg bekrefter å ha gitt informasjon om studien 
 
 
---------------------------------------------------------------------------------------------------------------- 
(Signert, rolle i studien, dato) 
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13. Appendix 3 
 
 
 
 
 
 
Sets Reps Load Sets Reps Load Sets Reps Load
Hammersquat 2 12 RM 2 10 90% of 12RM 1 8 RM
Leg press 1 12 RM 2 10 90% of 12RM 2 8 RM
Kne extensions 2 12 RM 2 10 90% of 12RM 2 8 RM
Calf raise 2 12 RM 2 10 90% of 12RM 2 8 RM
Chest press 1 12 RM 1 10 90% of 12RM 1 8 RM
Seated row 1 12 RM 1 10 90% of 12RM 1 8 RM
Close grip pull-down 1 10 RM
Shoulder press 1 12 RM 1 10 90% of 12RM 1 8 RM
Back extensions 1 max 20 1 max 20 1 max 20
Ab crunch 1 max 20 1 max 20 1 max 20
Sets Reps Load Sets Reps Load Sets Reps Load
Hammersquat 2 10 RM 2 10 90% of 10RM 1 6 RM
Leg press 1 10 RM 2 10 90% of 10RM 2 6 RM
Kne extensions 2 10 RM 2 10 90% of 10RM 2 6 RM
Calf raise 2 10 RM 2 10 90% of 10RM 2 6 RM
Chest press 1 10 RM 1 10 90% of 10RM 1 6 RM
Seated row 1 10 RM 1 10 90% of 10RM 1 6 RM
Close grip pull-down 1 10 RM
Shoulder press 1 10 RM 1 10 90% of 10RM 1 6 RM
Back extensions 1 max 15 1 max 15 1 max 15
Ab crunch 1 max 15 1 max 15 1 max 15
Sets Reps Load Sets Reps Load Sets Reps Load
Hammersquat 2 10 RM 2 10 90% of 10RM 2 6 RM
Leg press 2 10 RM 3 10 90% of 10RM 3 6 RM
Kne extensions 3 10 RM 2 10 90% of 10RM 3 6 RM
Calf raise 2 10 RM 2 10 90% of 10RM 2 6 RM
Chest press 2 10 RM 2 10 90% of 10RM 2 6 RM
Seated row 2 10 RM 2 10 90% of 10RM 2 6 RM
Close grip pull-down 2 10 RM
Shoulder press 2 10 RM 2 10 90% of 10RM 2 6 RM
Back extensions 1 max 15 1 max 15 1 max 15
Ab crunch 1 max 15 1 max 15 1 max 15
Sets Reps Load Sets Reps Load Sets Reps Load
Hammersquat 3 8 RM 3 8 90% of 8RM 2 6 RM
Leg press 2 8 RM 3 8 90% of 8RM 3 6 RM
Kne extensions 3 8 RM 2 8 90% of 8RM 3 6 RM
Calf raise 2 8 RM 2 8 90% of 8RM 2 6 RM
Chest press 3 8 RM 2 8 90% of 8RM 2 6 RM
Close grip pull-down 2 10 RM
Seated row 2 8 RM 2 8 90% of 8RM 2 6 RM
Shoulder press 2 8 RM 2 8 90% of 8RM 2 6 RM
Back extensions 1 max 10 1 max 10 1 max 10
Ab crunch 1 max 10 1 max 10 1 max 10
Monday Wednesday Friday
7-9
10-12
4-6
1-3
Week Exercise
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14. Appendix 4 
 
WESTERN BLOT - PROTOKOLL      
   
Forberedelser 
SDS-running buffer: 200ml SDS + 1800ml dH2O 
Tris/glycine Transfer buffer: 200 ml metanol + 200ml Tris/glycine + 1600 ml dH2O 
TBS: 100mL TBS + 900 mL ultrarent vann 
TBS-T: 200 mL TBS + 1800 mL ultrarent vann + 2 mL tween 20. 
Ultrarent vann: 3 L 
 Lag 5 % melkeløsning: 20 g melkepulver + 400 mL TBS-T (røres med 
magnet) 
 Mengde beregnet for 1 boks (2 membraner). Settes i kjøleskap over natt. 
DAG 1 
KLARGJØRING. BLANDE PRØVER 
 Ta TBS, TBS-T  og melkeblanding ut av kjøleskapet. 
 Sett varmeblokk på 60° C (faktisk temperatur: 70° C). Dobbeltsjekk at den 
faktisk er påslått, og at riktig blokk står i. Hent ut prøver fra fryseren. 
 Lag sample buffer: Bland 336 uL Laemmli sample buffer og  14 uL 5MDT i et 
eget 1,5 ml rør. 
 Bland prøve, H20, sample buffer i henhold til «sample preparation mal». 
 «Sample preparation mal» finner man under SFP group -> analyselab -> 
SOP-prosedyrer. 
 Print også ut «NuPAGE ELFO  WB»-skjema. 
 Sett merkede eppendorfrør på varmeblokk i 10 min ved 70°. Sett på 
stoppeklokke! 
 MENS PRØVEN STÅR PÅ VARMEBLOKK 
 Finn fram: 4 geler til hver boks som skal kjøres, running buffer, 
elektroforeseboks (den største av boksene) og GeneOn markør 
 Husk prøvene på varmeblokka! 
 Klipp opp plasten på gelene, og tørk av. Ta av grønn tape under gelen og fjern 
kammen. 
 Sett gelene i boksen med ”brønnene innover”. Dytt gelene godt ned og lukk 
igjen klemmen. 
 ELEKTROFORESE 
 Fyll indre kammer med SDS running buffer (sjekk at det ikke lekker i ytre 
kammer). 
 Sett 5 uL markør i brønn 1 og 10 på begge sider (bruk lilla tynn pipette) 
 Sett 30 uL prøve i de øvrige brønnene. (Bruk lilla tynn pipette) 
 Ytre kammer fylles 2/3 fullt med running buffer. 
 Sett på lokk, montér ledninger, slå på og still inn volt (200 V) og tid ca 40 min 
 Sjekk at strømmen lager bobler i indre bufferkammer.  
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MENS ELEKTROFORESEN GÅR – AKTIVERE PVDF-MEMBRANENE 
(husk å ta bilder av gelene etter elektroforesen) 
 Klipp opp 4 PVDF-membraner per elektroforese-kammer og legg disse i 
lyseblå boks. Skriv nummer øverst i venstre hjørne av membranen og klipp et 
hakk øverst i høyre hjørne.  
 Finn frem 24 filterpapir og 4 pads. 
 Pads legges i transfer buffer i lilla boks i >15 min (klem ut luftbobler). 
 PVDF-membraner aktiveres på følgende måte (i en tilstrekkelig romslig boks): 
o 30 sek i metanol 
o 30 sek i dH2O 
o 1-2 min i nytt dH2O 
o 10-15 min i transferbuffer 
 Filterpapir legges i transferbuffer i lilla boks like før bruk. 
BLOTTING 
 Finn frem: blottedelen til boksene, lilla bokser, pinsett, grønn spade, penn, 
tørkepapir, rulle og gul avfallsboks. 
 Slå av, trekk ut ledninger. Ta ut en gel om gangen, og tørk av. Ta ut den 
fremste gelen først. 
 Knekk opp med en spade. Løft av den minste platen fra motsatt side av buen. 
 Fjern brønnene. Skjær av nedre del av gelen, og lag sandwich (blank del 
liggende i plastbrett dekket av transferbuffer): 
o Pad 
o Filterpapir + membran (bruk rulle for god kontakt) 
o Gel 
o Filterpapir 
o Pad 
 Skyll elektroforesekammer i dH2O, og monter sandwichen i kammeret. Svart 
mot svart, blank mot rødt. 
 Fyll indre kammer med transferbuffer. 
 Legg i roterende magnet i bunnen i ytre kammer og legg i frossent 
kjøleelement. 
 Fyll kammer fullt med transfer buffer (så det dekker øvre del av padsene i 
sandwichen) 
 Sett på lokk, montér ledninger. Sjekk at elektrodene sitter i sporene slik de 
skal. 
 Blotting: 100V, 30 min. 
NÅR BLOTTING ER IGANGSATT 
 Rydd det som kan ryddes. 
 
NÅR BLOTTINGEN ER FERDIG: Ta bilder av membran og geler! 
Etter bilder: KUTTING 
 Bruk pasteurpipette til å fukte glassplaten 
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 Legg membranen på glassplaten med proteinsiden opp, og bruk linjal og 
blyant for å tegne opp hvor det skal kuttes. Kutt på 120, på 82, rett under 62 
og rett under 26. 
 Skriv nytt navn til høyre på hver membrandel, og kutt i vei. 
 Proteinvekt:  eEF2: ca 95 kDA 
P70: ca 70 kDA 
4E-BP1: 15-20 kDA 
BLOKKERING 
 Tøm 5 % melkeløsning i en lyseblå boks. Fyll dH2O i en lilla boks. 
 Slå av, trekk ut ledninger, ta ut og åpne blottmodulen over lilla plastboks. 
 Legg pads i dH2O (må ikke komme i kontakt med deconex). Filtrene kastes. 
Membraner legges i en boks med TBS. 
 Dekk til med parafilm, og sett boksen på gyrorockeren i 2 timer (hastighet: 
20). 
 Finn glassplate, kniv, linjal, blyant, pasteurpipette, markørvektskjema, og boks 
med TBS.  
 Finn fram rør for primært antistoff-løsning, og merk disse med antistoff, 
initialer og dato. 
 Vask elektroforese-kamrene. 
 1 time pause.  
VASKING 
 Tøm ut melkeløsningen fra boksen med membranene. 
 Skyll 2 ganger i romtemperert TBS-T. 
 Skyll 2 x 2 min i TBS-T på gyrorocker (hastighet: 65). 
 INKUBERING I PRIMÆRT ANTISTOFF (FOSFO-PROTEINER) 
 Finn fram antistoff for de fosfoproteinene som skal studeres. 
 Lag 1 % melkeløsning: Bland 10 mL 5 % melkeløsning med 40 mL TBS-T. 
 Antistoff tines og spinnes ned. 
 Pipetter 5 mL 1 % melkeløsning i hvert rør, og pipetter primært antistoff i 
riktig rør. 
 Ta membranene opp av TBS-T-løsningen og rull dem med proteinsiden inn 
(tallet inn). 
 Legg rørene på roller mikser i kjøleskap over natt (hastighet: 7). 
 Sett TBS, TBS-T, dH2O og 5 % melkeløsning i kjøleskap. 
DAG 2 
VASKING 
 Ta TBS, TBS-T og melkeløsning ut av kjøleskapet (TBS og TBS-T røres og 
varmes). 
 Bruk pinsett for å ta membranene ut av rørene. Ta vare på rørene med 
antistoffer (?). 
 Legg membranene i lyseblå plastboks og skyll to ganger i TBS-T. 
 1 x 15 min i TBS-T på gyrorocker (hastighet: 65). 
 3x 5 min i TBS på gyrorocker (hastighet: 65). 
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 INKUBERING I SEKUNDÆRT ANTISTOFF 
 Lag 1 % melkeløsning: Bland 20 mL 5 % melkeløsning med 80 mL TBS-T 
med magnet. 
 Tilsett 30 mL 1 % melkeløsning i forholdsvis liten plastboks, og tilsett 10 uL 
sekundært antistoff (goat-anti-rabbit, 1:3000 fortynning).  
 Følgende membraner skal ha goat-anti-rabbit som sekundært antistoff: fosfo 
p70, fosfo eEF2, og fosfo 4E-BP1. 
 Legg membranene i løsningen med proteinsiden opp, og inkubér i 1 time på 
gyrorocker (hastighet: 20). Bruk lokk/parafilm. 
 60 min pause. 
VASKING 
 Tøm ut melkeløsningen fra boksen med membranene. 
 Skyll 2 ganger i romtemperert TBS-T. 
 1 x 15 min i TBS-T på gyrorocker (hastighet: 65). 
 3 x 5 min i TBS på gyrorocker (hastighet: 65). 
BILDER 
 Mens membranene vaskes: Finn fram et lite rør og pakk det inn i 
aluminiumsfolie. 
 Bland substratvæske, vend på røret og sett i skap (omtrent 2 mL total mengde 
per bilde). 
 Lag oppsett for billedtagningen. Velg: new single channel  blots  chemi 
hi sensitivity 
 Ta bilder med proteinsiden opp. Velg et bilde og lagre. 
STRIPPING, VASKING OG BLOKKERING 
 Strip membranene med «Restore PLUS Western blot stripping buffer» i 10 
min på gyrorocker 
 Skyll membranene 5 x 1 min i TBS. Benytt ny plastboks. 
 3 x 5 min i TBS på gyrorocker (hastighet: 65). 
 Blokkér i 5 % melkeløsning i 120 min. 
 1 % melkeløsning: Bland 10 mL 5 % melkeløsning med 40 mL TBS-T 
(forberedelse til antistoff-inkubering) 
 Finn fram rør for primært antistoff-løsning, og merk disse med antistoff, 
initialer og dato. 
VASKING 
 Tøm ut melkeløsningen fra boksen med membranene. 
 Skyll 2 ganger i romtemperert TBS-T. 
 Skyll 2 x 2 min i TBS-T på gyrorocker (hastighet: 65). 
INKUBERING I PRIMÆRT ANTISTOFF (TOTAL-PROTEINER) 
 Finn fram antistoff for de total-proteiner som skal studeres. 
 Antistoff tines og spinnes ned. 
 Pipetter 5 mL eller 10 uL 1 % melkeløsning i hvert rør/boks, samt riktig 
primært antistoff. 
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 Ta membranene opp av TBS-T-løsningen og rull dem med proteinsiden inn 
(tallet inn). 
 Legg rørene på roller mikser i kjøleskap over natt (hastighet: 7). 
 Sett TBS, TBS-T og 5 % melkeløsning i kjøleskap. 
 
DAG 3 
VASKING 
 Ta TBS, TBS-T og melkeløsning ut av kjøleskapet (TBS og TBS-T røres og 
varmes). 
 Bruk pinsett for å ta membranene ut av rørene. Ta vare på rørene med 
antistoffer (?) 
 Legg membranene i lyseblå plastboks og skyll to ganger i TBS-T. 
 1 x 15 min i TBS-T på gyrorocker (hastighet: 65). 
 3 x 5 min i TBS på gyrorocker (hastighet: 65). 
INKUBERING I SEKUNDÆRT ANTISTOFF 
 Lag 1 % melkeløsning: Bland 20 mL 5 % melkeløsning med 80 mL TBS-T 
med magnet. 
 Tilsett 30 mL 1 % melkeløsning i forholdsvis liten plastboks, og tilsett 10 uL 
sekundært antistoff (goat-anti-rabbit, 1:3000 fortynning).  
 Følgende membraner skal ha goat-anti-rabbit som sekundært antistoff: Total 
p70, Total eEF2 og Total 4E-BP1. 
 Legg membranene i løsningen med proteinsiden opp, og inkubér i 1 time på 
gyrorocker (hastighet: 20). Bruk lokk/parafilm. 
VASKING 
 Tøm ut melkeløsningen fra boksen med membranene. 
 Skyll 2 ganger i romtemperert TBS-T. 
 1 x 15 min i TBS-T på gyrorocker (hastighet: 65). 
 3 x 5 min i TBS på gyrorocker (hastighet: 65). 
BILDER 
 Mens membranene vaskes: Finn fram et lite rør og pakk det inn i 
aluminiumsfolie. 
 Bland substratvæske, vend på røret og sett i skap (omtrent 2 mL total mengde 
per bilde). 
 Lag oppsett for billedtagningen. Velg: new single channel  blots  chemi 
hi sensitivity 
 Ta bilder med proteinsiden opp. Velg et bilde og lagre. 
 
 

